{ "version": "2.2", "instance": { "dhacu-20231231x10k.htm": { "nsprefix": "dhacu", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "dts": { "schema": { "local": [ "dhacu-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd" ] }, "calculationLink": { "local": [ "dhacu-20231231_cal.xml" ] }, "definitionLink": { "local": [ "dhacu-20231231_def.xml" ] }, "labelLink": { "local": [ "dhacu-20231231_lab.xml" ] }, "presentationLink": { "local": [ "dhacu-20231231_pre.xml" ] }, "inline": { "local": [ "dhacu-20231231x10k.htm" ] } }, "keyStandard": 189, "keyCustom": 179, "axisStandard": 18, "axisCustom": 0, "memberStandard": 18, "memberCustom": 65, "hidden": { "total": 43, "http://digitalhealthacquisitioncorp.com/20231231": 20, "http://xbrl.sec.gov/dei/2023": 6, "http://fasb.org/us-gaap/2023": 17 }, "contextCount": 283, "entityCount": 1, "segmentCount": 90, "elementCount": 647, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 502, "http://xbrl.sec.gov/dei/2023": 44, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R2": { "role": "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "longName": "00100 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:AssetsCurrent", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R3": { "role": "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical", "longName": "00105 - Statement - CONSOLIDATED BALANCE SHEET (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEET (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_StatementClassOfStockAxis_dhacu_CommonStockSubjectToRedemptionMember_PqJ4P1VRV0mxDwZGVZyWqw", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "Unit_Divide_USD_shares_Dz7FJmfRuUiJhzKcnpDC6A", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_StatementClassOfStockAxis_dhacu_CommonStockSubjectToRedemptionMember_PqJ4P1VRV0mxDwZGVZyWqw", "name": "us-gaap:TemporaryEquityRedemptionPricePerShare", "unitRef": "Unit_Divide_USD_shares_Dz7FJmfRuUiJhzKcnpDC6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R4": { "role": "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations", "longName": "00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:OperatingCostsAndExpenses", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:OperatingIncomeLoss", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R5": { "role": "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "longName": "00300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_G0P26-YwgEO83dUYO6OcxQ", "name": "us-gaap:StockholdersEquity", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_G0P26-YwgEO83dUYO6OcxQ", "name": "us-gaap:StockholdersEquity", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R6": { "role": "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical", "longName": "00305 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical)", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "Duration_3_30_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_8yxWcYHLQkmoM91ONOkauw", "name": "dhacu:NumberOfWarrantsIssued", "unitRef": "Unit_Standard_shares_ftK61IXONkqcyJLKUwtAog", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_3_30_2021_To_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_8yxWcYHLQkmoM91ONOkauw", "name": "dhacu:NumberOfWarrantsIssued", "unitRef": "Unit_Standard_shares_ftK61IXONkqcyJLKUwtAog", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R7": { "role": "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "longName": "00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:ProfitLoss", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R8": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations", "longName": "10101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R9": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies", "longName": "10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R10": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOffering", "longName": "10301 - Disclosure - INITIAL PUBLIC OFFERING", "shortName": "INITIAL PUBLIC OFFERING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:InitialPublicOfferingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:InitialPublicOfferingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R11": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacement", "longName": "10401 - Disclosure - PRIVATE PLACEMENT", "shortName": "PRIVATE PLACEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:PrivatePlacementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:PrivatePlacementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R12": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactions", "longName": "10501 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R13": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitments", "longName": "10601 - Disclosure - COMMITMENTS", "shortName": "COMMITMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R14": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficit", "longName": "10701 - Disclosure - STOCKHOLDERS' DEFICIT", "shortName": "STOCKHOLDERS' DEFICIT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R15": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrants", "longName": "10801 - Disclosure - WARRANTS", "shortName": "WARRANTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:WarrantsNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:WarrantsNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R16": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTax", "longName": "10901 - Disclosure - INCOME TAX", "shortName": "INCOME TAX", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R17": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurements", "longName": "11001 - Disclosure - FAIR VALUE MEASUREMENTS", "shortName": "FAIR VALUE MEASUREMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R18": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEvents", "longName": "11101 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R19": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "longName": "20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "19", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R20": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "longName": "30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:SharesSubjectToMandatoryRedemptionDisclosureTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "dhacu:TemporaryEquityPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:SharesSubjectToMandatoryRedemptionDisclosureTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "dhacu:TemporaryEquityPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R21": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxTables", "longName": "30903 - Disclosure - INCOME TAX (Tables)", "shortName": "INCOME TAX (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R22": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables", "longName": "31003 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:HeldToMaturitySecuritiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:HeldToMaturitySecuritiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R23": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "longName": "40101 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "unitRef": "Unit_Standard_item_mouLLQKKmEyI5gWvTyUEHg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "unitRef": "Unit_Standard_item_mouLLQKKmEyI5gWvTyUEHg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R24": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "longName": "40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:WorkingCapital", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "dhacu:LiquidityAndGoingConcernPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R25": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails", "longName": "40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock Reflected in the Condensed Consolidated Balance Sheet (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock Reflected in the Condensed Consolidated Balance Sheet (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:TemporaryEquityCarryingAmountAttributableToParent", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2021_us-gaap_StatementClassOfStockAxis_dhacu_CommonStockSubjectToRedemptionMember_1jh6tnXy40eH6pf2NSWA5w", "name": "dhacu:TemporaryEquityPortionOfBalanceAttributableToProceedsFromIssuanceInitialPublicOffering", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "dhacu:SharesSubjectToMandatoryRedemptionDisclosureTableTextBlock", "dhacu:TemporaryEquityPolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R26": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCalculationOfBasicAndDilutedNetLossPerCommonStockDetails", "longName": "40203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Calculation of basic and diluted net loss per common stock (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Calculation of basic and diluted net loss per common stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "longName": "40301 - Disclosure - INITIAL PUBLIC OFFERING (Details)", "shortName": "INITIAL PUBLIC OFFERING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "unitRef": "Unit_Standard_shares_ftK61IXONkqcyJLKUwtAog", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "dhacu:WarrantsNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_11_8_2021_To_11_8_2021_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_VKK8TOacokqjgfZUyt8qpw", "name": "dhacu:NumberOfSharesIssuedPerUnit", "unitRef": "Unit_Standard_shares_ftK61IXONkqcyJLKUwtAog", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "dhacu:InitialPublicOfferingTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R28": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "longName": "40401 - Disclosure - PRIVATE PLACEMENT (Details)", "shortName": "PRIVATE PLACEMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "dhacu:SaleOfStockUnderwritingFees", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:NatureOfOperations", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": null }, "R29": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "longName": "40501 - Disclosure - RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "shortName": "RELATED PARTY TRANSACTIONS - Founder Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": null }, "R30": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "longName": "40502 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:RepaymentsOfRelatedPartyDebt", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:ProceedsHeldInTrustAccountUsedToRepayWorkingCapitalLoans", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R31": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "longName": "40601 - Disclosure - COMMITMENTS (Details)", "shortName": "COMMITMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "As_Of_11_3_2021_KO6dQbmPE0CtC2319SILSQ", "name": "dhacu:MaximumNumberOfDemandsForRegistrationOfSecurities", "unitRef": "Unit_Standard_item_mouLLQKKmEyI5gWvTyUEHg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_11_3_2021_KO6dQbmPE0CtC2319SILSQ", "name": "dhacu:MaximumNumberOfDemandsForRegistrationOfSecurities", "unitRef": "Unit_Standard_item_mouLLQKKmEyI5gWvTyUEHg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R32": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "longName": "40602 - Disclosure - COMMITMENTS - Bridge Securities Purchase Agreement (Details)", "shortName": "COMMITMENTS - Bridge Securities Purchase Agreement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "unitRef": "Unit_Standard_shares_ftK61IXONkqcyJLKUwtAog", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "dhacu:WarrantsNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_10_6_2022_To_10_6_2022_us-gaap_DebtInstrumentAxis_dhacu_BridgeNotesMember_us-gaap_RelatedPartyTransactionAxis_dhacu_BridgeSecuritiesPurchaseAgreementMember_vLEePk1V8kGd0N0Wdfg6CQ", "name": "dhacu:PercentageOfUnpaidPrincipalDueAndPayableIfPipeFinancingClosedAtClosingOfBusinessCombination", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R33": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "longName": "40603 - Disclosure - COMMITMENTS - Defaulted Bridge Notes (Details)", "shortName": "COMMITMENTS - Defaulted Bridge Notes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "Duration_10_4_2023_To_10_4_2023_us-gaap_DebtInstrumentAxis_dhacu_BridgeNotesMember_C5k_X8lSjUCc7kLQ54HSUw", "name": "dhacu:DebtDefaultPercentageOfMandatoryPenalty", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_4_2023_To_10_4_2023_us-gaap_DebtInstrumentAxis_dhacu_BridgeNotesMember_C5k_X8lSjUCc7kLQ54HSUw", "name": "dhacu:DebtDefaultPercentageOfMandatoryPenalty", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R34": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "longName": "40604 - Disclosure - COMMITMENTS - Exchange Note Exchange Financing (Details)", "shortName": "COMMITMENTS - Exchange Note Exchange Financing (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "Duration_11_21_2023_To_11_21_2023_AmVHOhnSB0y9-hgb1PohPw", "name": "dhacu:DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice", "unitRef": "Unit_Divide_USD_shares_Dz7FJmfRuUiJhzKcnpDC6A", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_ExchangeNotesMember_FFp0lvvDL0y5S9z-ed5QVg", "name": "dhacu:DebtInstrumentConvertibleThresholdTradingDaysForAmortizationConversionPrice", "unitRef": "Unit_Standard_D_28-tlAyYzkyB6MTMKyiy_g", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R35": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "longName": "40605 - Disclosure - COMMITMENTS - Additional Bridge Financing (Details)", "shortName": "COMMITMENTS - Additional Bridge Financing (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "Duration_11_21_2023_To_11_21_2023_AmVHOhnSB0y9-hgb1PohPw", "name": "dhacu:DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice", "unitRef": "Unit_Divide_USD_shares_Dz7FJmfRuUiJhzKcnpDC6A", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_11_21_2023_To_11_21_2023_us-gaap_DebtInstrumentAxis_dhacu_AdditionalBridgePromissoryNotesMember_us-gaap_RelatedPartyTransactionAxis_dhacu_BridgeLetterAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dhacu_BridgeInvestorMember_aD3dCruh70m3mFvFvzbBtw", "name": "dhacu:DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice", "unitRef": "Unit_Divide_USD_shares_Dz7FJmfRuUiJhzKcnpDC6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R36": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "longName": "40606 - Disclosure - COMMITMENTS - Extension Note (Extension Financing) and Bifurcated Derivative (Details)", "shortName": "COMMITMENTS - Extension Note (Extension Financing) and Bifurcated Derivative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "Unit_Divide_USD_shares_Dz7FJmfRuUiJhzKcnpDC6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "dhacu:WarrantsNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_5_5_2023_To_5_5_2023_us-gaap_DebtInstrumentAxis_dhacu_ExtensionNotesMember_ApshPuB2zkyG7LSf6jNvNA", "name": "dhacu:PercentageOfOriginalIssueDiscount", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R37": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "longName": "40607 - Disclosure - COMMITMENTS - Quantum Financing Securities Purchase Agreement (Details)", "shortName": "COMMITMENTS - Quantum Financing Securities Purchase Agreement (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "Duration_11_21_2023_To_11_21_2023_AmVHOhnSB0y9-hgb1PohPw", "name": "dhacu:DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice", "unitRef": "Unit_Divide_USD_shares_Dz7FJmfRuUiJhzKcnpDC6A", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_11_21_2023_To_11_21_2023_us-gaap_DebtInstrumentAxis_dhacu_QuantumNoteMember_us-gaap_RelatedPartyTransactionAxis_dhacu_QuantunPurchaseAgreementMember_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_dhacu_QuantumInvestorMember_X9MGJITB00uvSgHHuXEjGg", "name": "dhacu:PercentageOfOriginalIssueDiscount", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R38": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "longName": "40608 - Disclosure - COMMITMENTS - Equity Financing (Details)", "shortName": "COMMITMENTS - Equity Financing (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "Duration_11_21_2023_To_11_21_2023_AmVHOhnSB0y9-hgb1PohPw", "name": "dhacu:MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement", "unitRef": "Unit_Standard_item_mouLLQKKmEyI5gWvTyUEHg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_11_21_2023_To_11_21_2023_AmVHOhnSB0y9-hgb1PohPw", "name": "dhacu:MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement", "unitRef": "Unit_Standard_item_mouLLQKKmEyI5gWvTyUEHg", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R39": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "longName": "40701 - Disclosure - STOCKHOLDERS' DEFICIT - Common Shares (Details)", "shortName": "STOCKHOLDERS' DEFICIT - Common Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_5_5_2023_To_5_5_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_7FCCa7yOL06-kHZr6ljhQA", "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "unitRef": "Unit_Standard_shares_ftK61IXONkqcyJLKUwtAog", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R40": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails", "longName": "40801 - Disclosure - WARRANTS (Details)", "shortName": "WARRANTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Unit_Standard_shares_ftK61IXONkqcyJLKUwtAog", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:ClassOfWarrantOrRightOutstanding", "p", "dhacu:WarrantsNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:NumberOfWarrantsExercisableForCash", "unitRef": "Unit_Standard_shares_ftK61IXONkqcyJLKUwtAog", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "dhacu:WarrantsNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R41": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails", "longName": "40802 - Disclosure - WARRANTS - Bridge Warrants (Details)", "shortName": "WARRANTS - Bridge Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "Unit_Divide_USD_shares_Dz7FJmfRuUiJhzKcnpDC6A", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "dhacu:WarrantsNoteDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_5_5_2023_To_5_5_2023_us-gaap_ClassOfWarrantOrRightAxis_dhacu_ExtensionWarrantsMember_us-gaap_TypeOfArrangementAxis_dhacu_ExtensionPurchaseAgreementMember_h5ii6Ai05UyYQp7MbM9HSQ", "name": "dhacu:NumberOfWarrantsIssued", "unitRef": "Unit_Standard_shares_ftK61IXONkqcyJLKUwtAog", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R42": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfNetDeferredTaxAssetsDetails", "longName": "40901 - Disclosure - INCOME TAX - Schedule of net deferred tax assets (Details)", "shortName": "INCOME TAX - Schedule of net deferred tax assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:DeferredTaxAssetsLiabilitiesNet", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:DeferredTaxAssetsLiabilitiesNet", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:DeferredTaxAssetsLiabilitiesNet", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:DeferredTaxAssetsLiabilitiesNet", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R43": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetails", "longName": "40902 - Disclosure - INCOME TAX - Schedule of Income tax provision (Details)", "shortName": "INCOME TAX - Schedule of Income tax provision (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "Duration_1_1_2022_To_12_31_2022_b7DkR65-kEW57Slxsr4h7g", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2022_To_12_31_2022_b7DkR65-kEW57Slxsr4h7g", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R44": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails", "longName": "40903 - Disclosure - INCOME TAX - Summary of reconciliation of the federal income tax rate to the Company's effective tax rate (Details)", "shortName": "INCOME TAX - Summary of reconciliation of the federal income tax rate to the Company's effective tax rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R45": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxDetails", "longName": "40904 - Disclosure - INCOME TAX (Details)", "shortName": "INCOME TAX (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R46": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "longName": "41001 - Disclosure - FAIR VALUE MEASUREMENTS - Additional information (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Additional information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "As_Of_12_31_2023_KQpELUSPIEWpPD-WdjtLWg", "name": "us-gaap:AssetsHeldInTrustNoncurrent", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "dhacu:AmountWithdrewFromTrustAccount", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R47": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails", "longName": "41002 - Disclosure - FAIR VALUE MEASUREMENTS (Details)", "shortName": "FAIR VALUE MEASUREMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_bP6MiMyQCESfs8_ioj_qCg", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:HeldToMaturitySecuritiesTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_MoneyMarketFundsMember_bP6MiMyQCESfs8_ioj_qCg", "name": "us-gaap:HeldToMaturitySecuritiesFairValue", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:HeldToMaturitySecuritiesTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R48": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "longName": "41003 - Disclosure - FAIR VALUE MEASUREMENTS - Fair value information on recurring basis (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Fair value information on recurring basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "As_Of_12_31_2022_JD2GPNBjAk6KLMpPKQE1LQ", "name": "dhacu:PipeForwardContractDerivative", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_ExtensionNoteBifurcatedDerivativeMember_ijb2aMXBuUWDIf8HWymsWw", "name": "dhacu:FairValueOfBifurcatedDerivative", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R49": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "longName": "41004 - Disclosure - FAIR VALUE MEASUREMENTS - Unobservable inputs for Bridge Note Bifurcate Derivative (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Unobservable inputs for Bridge Note Bifurcate Derivative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_dhacu_BridgeNotesMember_us-gaap_MeasurementInputTypeAxis_dhacu_MeasurementInputCccBondRateMember_SrWYrNAu-kWOGLVWQhoyzQ", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "dhacu:ScheduleOfBifurcatedDerivativeRatesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2022_us-gaap_DebtInstrumentAxis_dhacu_BridgeNotesMember_us-gaap_MeasurementInputTypeAxis_dhacu_MeasurementInputCccBondRateMember_SrWYrNAu-kWOGLVWQhoyzQ", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "dhacu:ScheduleOfBifurcatedDerivativeRatesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R50": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "longName": "41005 - Disclosure - FAIR VALUE MEASUREMENTS - Unobservable inputs for Extension Note Bifurcated Derivative (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Unobservable inputs for Extension Note Bifurcated Derivative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "As_Of_5_5_2023_us-gaap_DebtInstrumentAxis_dhacu_ExtensionNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_y67f7UXvTU-HT4Qt4cGLKQ", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_5_5_2023_us-gaap_DebtInstrumentAxis_dhacu_ExtensionNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_y67f7UXvTU-HT4Qt4cGLKQ", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R51": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails", "longName": "41006 - Disclosure - FAIR VALUE MEASUREMENTS - Unobservable inputs for PIPE Forward Contract (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Unobservable inputs for PIPE Forward Contract (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "As_Of_6_30_2023_us-gaap_FinancialInstrumentAxis_dhacu_PipeForwardContractMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_rLmizNs0ZUeKysHdw2vYmw", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_us-gaap_FinancialInstrumentAxis_dhacu_PipeForwardContractMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_rLmizNs0ZUeKysHdw2vYmw", "name": "us-gaap:DerivativeLiabilityMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R52": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "longName": "41007 - Disclosure - FAIR VALUE MEASUREMENTS - Unobservable inputs for Additional Bridge Note (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Unobservable inputs for Additional Bridge Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_AdditionalBridgePromissoryNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_10RDoxhh9kOlQVIzmsJftg", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_AdditionalBridgePromissoryNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_10RDoxhh9kOlQVIzmsJftg", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R53": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "longName": "41008 - Disclosure - FAIR VALUE MEASUREMENTS - Unobservable inputs for Exchange Note (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Unobservable inputs for Exchange Note (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_ExchangeNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_R4ry2UfhWk-BhPHpKpMEnA", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_ExchangeNotesMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_R4ry2UfhWk-BhPHpKpMEnA", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R54": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "longName": "41009 - Disclosure - FAIR VALUE MEASUREMENTS - Unobservable inputs for ELOC/Equity Financing (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Unobservable inputs for ELOC/Equity Financing (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_EquityLineOfCreditMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_r84amVaznkujDNAkcaWpSA", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_EquityLineOfCreditMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputRiskFreeInterestRateMember_r84amVaznkujDNAkcaWpSA", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "Unit_Standard_pure_cTqH7jh96E-odphbAJ7AWQ", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R55": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "longName": "41010 - Disclosure - FAIR VALUE MEASUREMENTS - Changes in the fair value of financial liabilities (Details)", "shortName": "FAIR VALUE MEASUREMENTS - Changes in the fair value of financial liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_ExchangeNotesMember_FFp0lvvDL0y5S9z-ed5QVg", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_us-gaap_DebtInstrumentAxis_dhacu_ExchangeNotesMember_FFp0lvvDL0y5S9z-ed5QVg", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } }, "R56": { "role": "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails", "longName": "41101 - Disclosure - SUBSEQUENT EVENTS (Details)", "shortName": "SUBSEQUENT EVENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "Duration_5_23_2023_To_5_23_2023_ItZcBCWEHE2I8gKDlkAI2g", "name": "dhacu:MinimumMarketValueOfListedSecurities", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_2_13_2024_To_2_13_2024_us-gaap_DebtInstrumentAxis_dhacu_VseeNoteMember_U_TvK1BqnkmTU8TTpgz_Og", "name": "dhacu:DebtInstrumentToBeConvertedAfterClosingBusinessCombination", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "unique": true } }, "R57": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Uncategorized", "order": "57", "firstAnchor": { "contextRef": "Duration_1_1_2023_To_12_31_2023_P_kqqv21fUGspYtVZDThZA", "name": "us-gaap:NetIncomeLoss", "unitRef": "Unit_Standard_USD_AcN5rbjJFE6e24tTd5UoLA", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true }, "uniqueAnchor": null }, "R58": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Cover", "order": "58", "firstAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_epQOsw_XZkGyW3rrF55tEw", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_10_1_2023_To_12_31_2023_epQOsw_XZkGyW3rrF55tEw", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "dhacu-20231231x10k.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r14" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued Income Taxes, Current", "terseLabel": "Income taxes payable", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r70", "r105" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Liabilities, Current", "terseLabel": "Due to related parties included in accrued expenses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r16" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r635" ] }, "dhacu_AdditionalAggregatePurchasePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AdditionalAggregatePurchasePrice", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents additional aggregate purchase price.", "label": "Additional Aggregate Purchase Price", "terseLabel": "Additional PIPE financing" } } }, "auth_ref": [] }, "dhacu_AdditionalBridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AdditionalBridgeNotesMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to additional bridge notes Member.", "label": "Additional Bridge Notes [Member]", "terseLabel": "Additional Bridge Note" } } }, "auth_ref": [] }, "dhacu_AdditionalBridgePromissoryNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AdditionalBridgePromissoryNotesMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to additional bridge promissory notes.", "label": "Additional Bridge Promissory Notes [Member]", "terseLabel": "Additional Bridge Promissory note", "verboseLabel": "Additional Bridge Notes" } } }, "auth_ref": [] }, "dhacu_AdditionalOfferingPercentageOfSecuritiesToBeOffered": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AdditionalOfferingPercentageOfSecuritiesToBeOffered", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of additional offering securities to the PIPE investors in additional offering.", "label": "Additional Offering, Percentage of Securities to be Offered", "terseLabel": "Percentage of additional offering securities in additional offerings" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r74", "r583", "r778" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r314", "r315", "r316", "r472", "r695", "r696", "r697", "r762", "r780" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r641" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r641" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r641" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r641" ] }, "dhacu_AdjustmentsToAdditionalPaidInCapitalExciseTaxOnRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AdjustmentsToAdditionalPaidInCapitalExciseTaxOnRedemption", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting due to excise tax payable on redemption of common stock.", "label": "Adjustments to Additional Paid in Capital, Excise Tax On Redemption", "negatedLabel": "Excise tax payable attributable to redemption of common stock" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "terseLabel": "Issuance of warrants issued with Bridge Note, net of offering costs", "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants." } } }, "auth_ref": [ "r8", "r39", "r96" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_AdministrativeFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdministrativeFeesExpense", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Administrative Fees Expense", "terseLabel": "Administrative fees expense", "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost." } } }, "auth_ref": [ "r64", "r513", "r779" ] }, "dhacu_AdministrativeSupportAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AdministrativeSupportAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for administrative support agreement.", "label": "Administrative Support Agreement [Member]", "terseLabel": "Administrative Services Agreement" } } }, "auth_ref": [] }, "dhacu_AffiliateOfSponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AffiliateOfSponsorMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for an affiliate of the sponsor.", "label": "Affiliate Of The Sponsor [Member]", "terseLabel": "Affiliate of the sponsor" } } }, "auth_ref": [] }, "dhacu_AggregateAmountDepositedIntoTrustAccountAsExtensionFees": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AggregateAmountDepositedIntoTrustAccountAsExtensionFees", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The aggregate amount deposited into trust account as extension fees.", "label": "Aggregate Amount Deposited Into Trust Account As Extension Fees", "terseLabel": "Aggregate amount deposited into trust account as extension fees" } } }, "auth_ref": [] }, "dhacu_AggregatePurchasePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AggregatePurchasePrice", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregate purchase price of shares issued.", "label": "Aggregate Purchase Price", "terseLabel": "Aggregate purchase price" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r605", "r617", "r627", "r653" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r608", "r620", "r630", "r656" ] }, "dhacu_AgreementLockUpPeriod": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AgreementLockUpPeriod", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the lock-up period under the agreement.", "label": "Agreement, Lock-up Period", "terseLabel": "Lock-up period (in months)" } } }, "auth_ref": [] }, "dhacu_AgreementNumberOfConsecutiveTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AgreementNumberOfConsecutiveTradingDays", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of consecutive trading days for release triggering date.", "label": "Agreement, Number of Consecutive Trading Days", "verboseLabel": "Agreement number of consecutive trading days" } } }, "auth_ref": [] }, "dhacu_AgreementStockPriceTrigger": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AgreementStockPriceTrigger", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the stock price trigger under agreement.", "label": "Agreement, Stock Price Trigger", "terseLabel": "Stock price trigger" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r641" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r648" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r612", "r621", "r631", "r648", "r657", "r661", "r669" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r667" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortized debt discount", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r7", "r60", "r84", "r256" ] }, "dhacu_AmountWithdrewFromTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AmountWithdrewFromTrustAccount", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash withdrew from trust account.", "label": "Amount Withdrew from Trust Account", "terseLabel": "Amount withdrew from Trust Account" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "verboseLabel": "Anti-dilutive securities attributable to warrants (in shares)", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r172" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r345" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r103", "r126", "r144", "r177", "r181", "r183", "r215", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r347", "r351", "r373", "r442", "r506", "r583", "r595", "r725", "r726", "r767" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total Current Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r123", "r130", "r144", "r215", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r347", "r351", "r373", "r583", "r725", "r726", "r767" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r57" ] }, "dhacu_AssetsHeldInTrustAccountPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "AssetsHeldInTrustAccountPolicyPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for assets held in trust.", "label": "Assets Held In Trust Account, Policy [Policy Text Block]", "terseLabel": "Investments Held in Trust Account" } } }, "auth_ref": [] }, "us-gaap_AssetsHeldInTrustNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsHeldInTrustNoncurrent", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Investments held in Trust Account", "verboseLabel": "Assets held in trust account", "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited." } } }, "auth_ref": [ "r690" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r599", "r600", "r613" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r599", "r600", "r613" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r599", "r600", "r613" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r664" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r665" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r660" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r660" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r660" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r660" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r660" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r660" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r663" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r662" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r661" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r661" ] }, "dhacu_BackstopAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BackstopAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Backstop Agreement.", "label": "Backstop Agreement [Member]", "terseLabel": "Backstop Agreement" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [TEXT BLOCK]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r89" ] }, "dhacu_BridgeExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BridgeExchangeAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for Bridge Exchange Agreement.", "label": "Bridge Exchange Agreement [Member]", "terseLabel": "Exchange Agreement" } } }, "auth_ref": [] }, "dhacu_BridgeInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BridgeInvestorMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for bridge investors.", "label": "Bridge Investor [Member]", "terseLabel": "Bridge Investor" } } }, "auth_ref": [] }, "dhacu_BridgeLetterAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BridgeLetterAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for Bridge Letter Agreement.", "label": "Bridge Letter Agreement [Member]", "terseLabel": "Bridge Letter Agreement" } } }, "auth_ref": [] }, "dhacu_BridgeNoteBifurcatedDerivativeMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BridgeNoteBifurcatedDerivativeMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for Bridge note bifurcated derivative.", "label": "Bridge Note Bifurcated Derivative [Member]", "terseLabel": "Bridge Note - Bifurcated Derivative" } } }, "auth_ref": [] }, "dhacu_BridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BridgeNotesMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Bridge Notes Member.", "label": "Bridge Notes [Member]", "terseLabel": "Bridge Notes" } } }, "auth_ref": [] }, "dhacu_BridgeNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BridgeNotesPayableCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "The amount of minimum gross proceeds of bridge notes to be paid in cash for consummation of subsequent placements.", "label": "Bridge Notes Payable Current", "terseLabel": "Bridge Note, net of discount" } } }, "auth_ref": [] }, "dhacu_BridgePromissoryNoteNetOfDiscountSettledWithExchangeNote": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BridgePromissoryNoteNetOfDiscountSettledWithExchangeNote", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of bridge promissory note, net of discount - settled with exchange note.", "label": "Bridge Promissory note, Net of Discount – Settled With Exchange Note", "terseLabel": "Bridge Promissory note, net of discount - settled with Exchange Note" } } }, "auth_ref": [] }, "dhacu_BridgeSecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BridgeSecuritiesPurchaseAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for Bridge Securities Purchase Agreement Member.", "label": "Bridge Securities Purchase Agreement [Member]", "terseLabel": "Bridge Securities Purchase Agreement" } } }, "auth_ref": [] }, "dhacu_BridgeWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BridgeWarrantsMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for Bridge Warrants.", "label": "Bridge Warrants [Member]", "terseLabel": "Bridge Warrants" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r343", "r578", "r579" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r50", "r51", "r343", "r578", "r579" ] }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Transaction Costs", "terseLabel": "Cash proceeds from the transactions", "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "terseLabel": "COMMITMENTS AND CONTINGENCIES", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r343" ] }, "dhacu_BusinessCombinationAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "BusinessCombinationAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to business combination agreement.", "label": "Business Combination Agreement [Member]", "terseLabel": "Business Combination Agreement" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "terseLabel": "Amount allocated", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r2", "r3", "r54", "r344" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Equity value of acquiree", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r52", "r53" ] }, "dhacu_CarryingValueOfTemporaryEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CarryingValueOfTemporaryEquityAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Carrying Value Of Temporary Equity [Abstract]", "terseLabel": "Common stock subject to possible redemption reflected on the condensed consolidated balance sheet" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r27", "r125", "r559" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r28" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash - End of year", "periodStartLabel": "Cash - Beginning of year", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r27", "r86", "r141" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Change in Cash", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r4", "r86" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r686", "r776" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "auth_ref": [] }, "dhacu_CashHeldOutsideTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CashHeldOutsideTrustAccount", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of cash held outside the trust account.", "label": "Cash Held Outside Trust Account", "terseLabel": "Cash held outside trust account" } } }, "auth_ref": [] }, "dhacu_ChangeInFairValueOfLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ChangeInFairValueOfLineOfCredit", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The change in fair value of line of credit during the period.", "label": "Change in Fair Value of Line Of Credit", "terseLabel": "Change in fair value of ELOC" } } }, "auth_ref": [] }, "dhacu_ChangeInFairValueOfPipeForwardContractDerivative": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ChangeInFairValueOfPipeForwardContractDerivative", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 3.0 }, "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Amount of change in fair value of pipe forward contract derivative.", "label": "Change in Fair Value of Pipe Forward Contract Derivative", "negatedLabel": "Change in fair value of PIPE Forward Contract Derivative", "terseLabel": "Change in fair value of PIPE Forward Contract Derivative" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r639" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r120", "r127", "r128", "r129", "r144", "r166", "r167", "r169", "r171", "r175", "r176", "r215", "r232", "r234", "r235", "r236", "r239", "r240", "r262", "r263", "r266", "r269", "r276", "r373", "r462", "r463", "r464", "r465", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r494", "r515", "r537", "r550", "r551", "r552", "r553", "r554", "r677", "r691", "r698" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "terseLabel": "STOCKHOLDERS' DEFICIT", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r127", "r128", "r129", "r175", "r262", "r263", "r264", "r266", "r269", "r274", "r276", "r462", "r463", "r464", "r465", "r574", "r677", "r691" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrants", "verboseLabel": "Warrants, exericse price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r277" ] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Line Items]", "terseLabel": "WARRANTS", "verboseLabel": "WARRANTS", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of shares for each warrant", "verboseLabel": "Number of shares per warrant", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "verboseLabel": "Warrants to purchase shares of common stock", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r277" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "dhacu_ClassOfWarrantOrRightPriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" ], "lang": { "en-us": { "role": { "documentation": "Price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Price of Warrants or Rights", "terseLabel": "Price of warrant", "verboseLabel": "Price of warrants" } } }, "auth_ref": [] }, "dhacu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days for redemption of public warrants" } } }, "auth_ref": [] }, "dhacu_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.", "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days", "terseLabel": "Threshold trading days for redemption of public warrants" } } }, "auth_ref": [] }, "dhacu_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Redemption price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights", "terseLabel": "Redemption price per public warrant (in dollars per share)" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r48" ] }, "dhacu_ClosingConsiderationMultiplicationFactorForCalculationOfAmountOfStockOptionExercisable": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ClosingConsiderationMultiplicationFactorForCalculationOfAmountOfStockOptionExercisable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the multiplication factor for calculation of amount for stock options exercisable.", "label": "Closing Consideration, Multiplication Factor for Calculation of Amount of Stock Option Exercisable", "terseLabel": "Closing consideration, multiplication factor for calculation of amount of stock option exercisable" } } }, "auth_ref": [] }, "dhacu_ClosingConsiderationNumeratorForCalculation": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ClosingConsiderationNumeratorForCalculation", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the numerator for calculation of closing consideration.", "label": "Closing Consideration, Numerator for Calculation", "terseLabel": "Numerator for calculation of closing consideration" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r640" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r640" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "terseLabel": "Commitments", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r20", "r66", "r443", "r493" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "COMMITMENTS" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitments" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r91", "r226", "r227", "r556", "r724" ] }, "dhacu_CommonStockIssuedAsFinancingCostInNote": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CommonStockIssuedAsFinancingCostInNote", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The amount of common stock issued as financing cost in note.", "label": "Common stock issued as financing cost in Note", "verboseLabel": "Common stock issued as financing cost in Extension Note" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r585", "r586", "r587", "r589", "r590", "r591", "r592", "r695", "r696", "r762", "r777", "r780" ] }, "dhacu_CommonStockNotSubjectToPossibleRedemptionMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CommonStockNotSubjectToPossibleRedemptionMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to common shares subject to not possible redemption.", "label": "Common Stock Not Subject to Possible Redemption [Member]", "terseLabel": "Common Stock Not Subject to Possible Redemption" } } }, "auth_ref": [] }, "dhacu_CommonStockNotSubjectToRedemptionMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CommonStockNotSubjectToRedemptionMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to common stock, shares not subject to possible redemption.", "label": "Common Stock Not Subject to Redemption [Member]", "terseLabel": "Common stock not subject to redemption" } } }, "auth_ref": [] }, "dhacu_CommonStockNumberOfVotesPerShare": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CommonStockNumberOfVotesPerShare", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of votes that each common share is entitled.", "label": "Common Stock, Number Of Votes Per Share", "terseLabel": "Common stock, votes per share" } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common shares, par value, (per share)", "verboseLabel": "Common stock, par value (in dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r73" ] }, "dhacu_CommonStockPercentageOfCapitalSharesReservedForFutureIssuance": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CommonStockPercentageOfCapitalSharesReservedForFutureIssuance", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of common shares reserved for future issuance.", "label": "Common Stock, Percentage of Capital Shares Reserved for Future Issuance", "terseLabel": "Percentage of shares reserved for issuance" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "verboseLabel": "Common stock, shares authorized (in shares)", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r73", "r494" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "verboseLabel": "Common stock, shares issued (in shares)", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r73" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "verboseLabel": "Common stock, shares outstanding (in shares)", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r73", "r494", "r512", "r780", "r781" ] }, "dhacu_CommonStockSubjectToRedemptionMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CommonStockSubjectToRedemptionMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to common shares subject to possible redemption.", "label": "Common Stock Subject to Redemption [Member]", "terseLabel": "Common stock subject to redemption", "verboseLabel": "Common stock subject to possible redemption" } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, $0.0001 par value; 50,000,000 shares authorized; 3,489,000 and 3,462,000 shares issued and outstanding (excluding 114,966 and 694,123 shares subject to redemption) as of December 31, 2023 and 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r73", "r444", "r583" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r645" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r644" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r646" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r643" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r68", "r115" ] }, "dhacu_ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum number of businesses which the reporting entity must acquire with the net proceeds of the offering.", "label": "Condition For Future Business Combination Number of a Businesses Minimum", "terseLabel": "Condition for future Business Combination number of businesses minimum" } } }, "auth_ref": [] }, "dhacu_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ConditionForFutureBusinessCombinationThresholdNetTangibleAssets", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.", "label": "Condition For Future Business Combination Threshold Net of Tangible Assets", "terseLabel": "Condition for future Business Combination threshold net tangible assets" } } }, "auth_ref": [] }, "dhacu_ConditionForFutureBusinessCombinationThresholdPercentageOwnership": { "xbrltype": "pureItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ConditionForFutureBusinessCombinationThresholdPercentageOwnership", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.", "label": "Condition For Future Business Combination On Threshold Percentage Ownership", "terseLabel": "Condition for future business combination threshold percentage ownership" } } }, "auth_ref": [] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r55", "r563" ] }, "dhacu_ConversionSecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ConversionSecuritiesPurchaseAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for Conversion Securities Purchase Agreement.", "label": "Conversion, Securities Purchase Agreement [Member]", "terseLabel": "Conversion Securities Purchase Agreement" } } }, "auth_ref": [] }, "dhacu_CostForIssuanceDateFairValueOfShares": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CostForIssuanceDateFairValueOfShares", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Cost for issuance date fair value of the shares", "label": "Cost For Issuance Date Fair Value of Shares", "terseLabel": "Cost for issuance date fair value of the shares" } } }, "auth_ref": [] }, "dhacu_CostForIssuanceDateFairValueOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "CostForIssuanceDateFairValueOfWarrants", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Cost for issuance date fair value of the Investor Warrants", "label": "Cost For Issuance Date Fair Value of Warrants", "terseLabel": "Cost for issuance date fair value of the warrants" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r148", "r149", "r244", "r264", "r389", "r560", "r562" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetailsImported": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Current", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r678", "r694", "r760" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtConversionOriginalDebtAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionOriginalDebtAmount1", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Original Debt, Amount", "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r29", "r31" ] }, "dhacu_DebtDefaultInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtDefaultInterestExpense", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The default amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Debt Default, Interest Expense", "negatedLabel": "Default interest expense", "terseLabel": "Interest expense on debt default" } } }, "auth_ref": [] }, "dhacu_DebtDefaultInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtDefaultInterestRate", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of interest for debt default.", "label": "Debt Default, Interest Rate", "terseLabel": "Default interest rate (as a percent)" } } }, "auth_ref": [] }, "us-gaap_DebtDefaultLongtermDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDefaultLongtermDebtAmount", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Debt Default, Amount", "terseLabel": "Total amount due", "documentation": "Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured." } } }, "auth_ref": [ "r142" ] }, "dhacu_DebtDefaultPercentageOfLateFee": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtDefaultPercentageOfLateFee", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of late fee for debt default.", "label": "Debt Default, Percentage of Late Fee", "terseLabel": "Late fee (as a percent)" } } }, "auth_ref": [] }, "dhacu_DebtDefaultPercentageOfMandatoryPenalty": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtDefaultPercentageOfMandatoryPenalty", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of mandatory penalty for debt default.", "label": "Debt Default, Percentage of Mandatory Penalty", "terseLabel": "Mandatory default penalty (as a percent)" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r12", "r69", "r70", "r104", "r106", "r150", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r381", "r569", "r570", "r571", "r572", "r573", "r692" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Gross", "terseLabel": "Principal due", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r12", "r106", "r258" ] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price of convertible notes", "verboseLabel": "Conversion price", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r92", "r243" ] }, "dhacu_DebtInstrumentConvertibleFloorAveragePriceForStockPriceTriggerForResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentConvertibleFloorAveragePriceForStockPriceTriggerForResetOfConversionPrice", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the floor average price for share price trigger which would be required to be attained for reset of conversion price.", "label": "Debt Instrument, Convertible, Floor Average Price for Stock Price Trigger for Reset of Conversion Price", "terseLabel": "Floor average price for share price trigger to determine reset of conversion price" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentConvertibleMaximumResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentConvertibleMaximumResetOfConversionPrice", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum reset of conversion price per share.", "label": "Debt Instrument, Convertible, Maximum Reset of Conversion Price", "terseLabel": "Maximum reset of conversion price (in dollars per share)" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentConvertibleMinimumConversionPriceToMakeAmortizationPayment": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentConvertibleMinimumConversionPriceToMakeAmortizationPayment", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum conversion price to make amortization payment.", "label": "Debt Instrument, Convertible, Minimum Conversion Price to make Amortization Payment", "terseLabel": "Minimum conversion price to make amortization payment" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Price of the entity's common stock which would be required to be attained for reset of conversion price.", "label": "Debt Instrument, Convertible, Stock Price Trigger for Reset of Conversion Price", "terseLabel": "Share price trigger to determine reset of conversion price" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Percentage of stock price trigger", "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion." } } }, "auth_ref": [] }, "dhacu_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTriggerForAmortizationConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTriggerForAmortizationConversionPrice", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine amortization conversion price.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger for Amortization Conversion Price", "terseLabel": "Threshold percentage of stock price trigger to determine amortization conversion price" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTriggerForResetOfConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTriggerForResetOfConversionPrice", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine reset value of conversion price.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger for Reset of Conversion Price", "terseLabel": "Threshold percentage of stock price trigger to determine reset of conversion price" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleThresholdTradingDays", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Threshold trading days", "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature." } } }, "auth_ref": [] }, "dhacu_DebtInstrumentConvertibleThresholdTradingDaysForAmortizationConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentConvertibleThresholdTradingDaysForAmortizationConversionPrice", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days prior to amortization payment to determine amortization conversion price.", "label": "Debt Instrument, Convertible, Threshold Trading Days for Amortization Conversion Price", "terseLabel": "Number of trading days to determine amortization payment" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentConvertibleThresholdTradingDaysForResetOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentConvertibleThresholdTradingDaysForResetOfConversionPrice", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days to determine reset of conversion price.", "label": "Debt Instrument, Convertible, Threshold Trading Days for Reset of Conversion Price", "terseLabel": "Number of trading days to determine reset of conversion price" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount", "verboseLabel": "Aggregate principal amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r61", "r63", "r241", "r381", "r570", "r571" ] }, "dhacu_DebtInstrumentFaceAmountNetOfEmbeddedDerivative": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentFaceAmountNetOfEmbeddedDerivative", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount allocated to the principal balance of the note after bifurcating with embedded derivative.", "label": "Debt Instrument, Face Amount, Net of Embedded Derivative", "terseLabel": "Amount allocated to the principal balance of the note" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Aggregate current value", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r249", "r372", "r570", "r571" ] }, "dhacu_DebtInstrumentFairValueAttributedToShares": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentFairValueAttributedToShares", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of relative value attributed to the Bridge Shares.", "label": "Debt Instrument Fair Value Attributed To Shares", "terseLabel": "Relative value attributed to the Bridge Shares" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentFinancingCosts", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of financing costs.", "label": "Debt Instrument Financing Costs", "terseLabel": "Amount of financing costs" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (in percent)", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r18", "r242" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Debt instruments", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r150", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r381", "r569", "r570", "r571", "r572", "r573", "r692" ] }, "us-gaap_DebtInstrumentMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMeasurementInput", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Measurement Input", "terseLabel": "Measurement input of notes payable", "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt." } } }, "auth_ref": [ "r368" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r19", "r150", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r381", "r569", "r570", "r571", "r572", "r573", "r692" ] }, "dhacu_DebtInstrumentOriginalIssuedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentOriginalIssuedDiscount", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of originally issued discount.", "label": "Debt Instrument Original Issued Discount", "terseLabel": "Originally issued discount" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentPrincipalAmountIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentPrincipalAmountIssuable", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the principal amount of debt issuable", "label": "Debt Instrument, Principal Amount Issuable", "terseLabel": "Principal amount of debt issuable" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentPrincipalAmountNotExchangeable": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentPrincipalAmountNotExchangeable", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The principal amount of debt that will not be exchangeable.", "label": "Debt Instrument, Principal Amount Not Exchangeable", "terseLabel": "Nonexchangeable debt", "verboseLabel": "Nonexchangeable principal amount of note" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentPrincipalAmountPurchasedOnLaterDate": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentPrincipalAmountPurchasedOnLaterDate", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The principal amount of debt which is purchased on the later date.", "label": "Debt Instrument, Principal Amount, Purchased On Later Date", "terseLabel": "Notes purchased on the later date" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentPrincipalAmountPurchasedOnSigningDate": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentPrincipalAmountPurchasedOnSigningDate", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The principal amount of debt which is purchased on the date of signing.", "label": "Debt Instrument, Principal Amount, Purchased On Signing Date", "terseLabel": "Notes purchased on the date of signing" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentPurchasePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentPurchasePrice", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The purchase price of debt instrument at the time of issuance.", "label": "Debt Instrument, Purchase Price", "terseLabel": "Purchase price" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentRelativeFairValueAttributedToWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentRelativeFairValueAttributedToWarrants", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of relative value attributed to the Bridge Warrants.", "label": "Debt Instrument Relative Fair Value Attributed To Warrants", "terseLabel": "Relative value attributed to the Bridge Warrants" } } }, "auth_ref": [] }, "dhacu_DebtInstrumentSubscriptionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentSubscriptionAmount", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The subscription amount of debt instrument at the date of issuance.", "label": "Debt Instrument, Subscription Amount", "terseLabel": "Aggregate subscription amount" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r19", "r44", "r47", "r60", "r61", "r63", "r67", "r94", "r95", "r150", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r381", "r569", "r570", "r571", "r572", "r573", "r692" ] }, "dhacu_DebtInstrumentToBeConvertedAfterClosingBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DebtInstrumentToBeConvertedAfterClosingBusinessCombination", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of the debt convertible after closing of business combination", "label": "Debt Instrument, to be Converted, After Closing Business Combination", "terseLabel": "Debt Instrument, to be Converted, After Closing Business Combination" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Amortizable debt discount", "verboseLabel": "Notes discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r60", "r63", "r728" ] }, "dhacu_DecreasesToTemporaryEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DecreasesToTemporaryEquityAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Decreases To Temporary Equity [Abstract]", "terseLabel": "Less:" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetailsImported": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Deferred", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r694", "r759", "r760" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "terseLabel": "Offering costs", "verboseLabel": "Financing cost", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r62", "r728" ] }, "dhacu_DeferredOfferingCostsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DeferredOfferingCostsNoncurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 }, "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails": { "parentTag": "dhacu_TransactionCosts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.", "label": "Deferred Offering Costs Noncurrent", "terseLabel": "Deferred underwriting fee payable" } } }, "auth_ref": [] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetailsImported": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "Deferred", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r694", "r759", "r760" ] }, "dhacu_DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DeferredTaxAssetsCapitalizedStartUpAndOrganizationCosts", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfComponentsOfCompanySNetDeferredTaxAssetsLiabilityDetailsImported": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "\" Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from capitalized start up and organization costs.\"", "label": "Deferred Tax Assets Capitalized Start Up And Organization Costs", "terseLabel": "Start-up/organization expenses" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfComponentsOfCompanySNetDeferredTaxAssetsLiabilityDetailsImported": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r330" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net", "totalLabel": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r758" ] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfComponentsOfCompanySNetDeferredTaxAssetsLiabilityDetailsImported": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Deferred tax assets, net of allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r758" ] }, "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance [Abstract]", "verboseLabel": "Deferred tax assets" } } }, "auth_ref": [] }, "dhacu_DeferredTaxAssetsNetOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DeferredTaxAssetsNetOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfComponentsOfCompanySNetDeferredTaxAssetsLiabilityDetailsImported": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible net operating loss carryforwards.", "label": "Deferred Tax Assets Net Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforward" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfComponentsOfCompanySNetDeferredTaxAssetsLiabilityDetailsImported": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfNetDeferredTaxAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r331" ] }, "dhacu_DeferredUnderwritingCommissionPercent": { "xbrltype": "pureItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DeferredUnderwritingCommissionPercent", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of gross proceeds from the initial public offering held in the trust account the underwriters are entitled to upon completion of a business combination.", "label": "Deferred Underwriting Commission, Percent", "terseLabel": "Deferred underwriting commission, as a percent" } } }, "auth_ref": [] }, "dhacu_DeferredUnderwritingFeeConsideredForPurchasePriceOfShares": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DeferredUnderwritingFeeConsideredForPurchasePriceOfShares", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The value of deferred underwriting fee considered for purchase price of shares.", "label": "Deferred Underwriting Fee Considered for Purchase Price of Shares", "terseLabel": "Deferred underwriting fee considered for purchase price of shares" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Derivative Liability, Current", "terseLabel": "Bifurcated Derivative", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r131" ] }, "us-gaap_DerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityMeasurementInput", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Liability, Measurement Input", "terseLabel": "Measurement input of forward contract", "documentation": "Value of input used to measure derivative liability." } } }, "auth_ref": [ "r368" ] }, "dhacu_DhacNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "DhacNoteMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to DHAC Note.", "label": "DHAC Note [Member]", "terseLabel": "DHAC Note" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r599", "r600", "r613" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r599", "r600", "r613", "r649" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "terseLabel": "Document and Entity Information", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r634" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCalculationOfBasicAndDilutedNetLossPerCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "verboseLabel": "Basic and diluted net loss per of common stock" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCalculationOfBasicAndDilutedNetLossPerCommonStockDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "terseLabel": "Basic net loss per common share (in dollars per share)", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r138", "r156", "r157", "r158", "r159", "r160", "r164", "r166", "r169", "r170", "r171", "r173", "r362", "r363", "r439", "r452", "r564" ] }, "us-gaap_EarningsPerShareBasicLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r166", "r167", "r169" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCalculationOfBasicAndDilutedNetLossPerCommonStockDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net loss per common share (in dollars per share)", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r138", "r156", "r157", "r158", "r159", "r160", "r166", "r169", "r170", "r171", "r173", "r362", "r363", "r439", "r452", "r564" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss per Common Stock", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r33", "r34" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate", "totalLabel": "Income tax provision", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r323" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory federal income tax rate", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r145", "r323", "r339" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r757", "r761" ] }, "dhacu_EffectiveIncomeTaxRateReconciliationFairValueChangesInEquityLineOfCredits": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationFairValueChangesInEquityLineOfCredits", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to fair value changes of additional bridge promissory notes.", "label": "Effective Income Tax Rate Reconciliation, Fair Value Changes in Equity Line of Credits", "terseLabel": "Change in fair value of ELOC" } } }, "auth_ref": [] }, "dhacu_EffectiveIncomeTaxRateReconciliationFairValueChangesOfAdditionalBridgePromissoryNote": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationFairValueChangesOfAdditionalBridgePromissoryNote", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to fair value changes of additional bridge promissory notes.", "label": "Effective Income Tax Rate Reconciliation, Fair Value Changes Of Additional Bridge Promissory Note", "terseLabel": "Change in fair value of Additional Bridge Note" } } }, "auth_ref": [] }, "dhacu_EffectiveIncomeTaxRateReconciliationFairValueChangesOfExchangeNote": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationFairValueChangesOfExchangeNote", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of effective income tax rate reconciliation fair value changes of exchange note.", "label": "Effective Income Tax Rate Reconciliation Fair Value Changes Of Exchange Note", "negatedLabel": "Change in fair value of Exchange Note" } } }, "auth_ref": [] }, "dhacu_EffectiveIncomeTaxRateReconciliationInitialFairValueOfAdditionalBridgePromissoryNote": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationInitialFairValueOfAdditionalBridgePromissoryNote", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to initial fair value of additional bridge promissory notes.", "label": "Effective Income Tax Rate Reconciliation, Initial Fair Value Of Additional Bridge Promissory Note", "terseLabel": "Initial fair value of Additional Bridge" } } }, "auth_ref": [] }, "dhacu_EffectiveIncomeTaxRateReconciliationInitialFairValueOfEquityLineOfCredit": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationInitialFairValueOfEquityLineOfCredit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to initial fair value of exchange notes.", "label": "Effective Income Tax Rate Reconciliation, Initial Fair Value Of Equity Line of Credit", "negatedLabel": "Initial fair value of ELOC" } } }, "auth_ref": [] }, "dhacu_EffectiveIncomeTaxRateReconciliationOfBridgeNoteBifurcatedDerivative": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationOfBridgeNoteBifurcatedDerivative", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of income tax rate reconciliation of Bridge Note Bifurcated Derivative.", "label": "Effective Income Tax Rate Reconciliation Of Bridge Note Bifurcated Derivative", "terseLabel": "Change in fair value of Bridge Note- bifurcated derivative" } } }, "auth_ref": [] }, "dhacu_EffectiveIncomeTaxRateReconciliationOfPipeForwardContractDerivative": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EffectiveIncomeTaxRateReconciliationOfPipeForwardContractDerivative", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of income tax rate reconciliation of PIPE Forward Contract Derivative.", "label": "Effective Income Tax Rate Reconciliation Of PIPE Forward Contract Derivative", "terseLabel": "Change in fair value of PIPE forward contract derivatives" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxSummaryOfReconciliationOfFederalIncomeTaxRateToCompanySEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State taxes, net of federal tax benefit", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r757", "r761" ] }, "dhacu_EmbeddedDerivativeBridgeNoteSettlementWithExchangeNote": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EmbeddedDerivativeBridgeNoteSettlementWithExchangeNote", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of embedded derivative from bridge notes settled with exchange notes.", "label": "Embedded Derivative, Bridge Note, Settlement with Exchange Note", "terseLabel": "Bridge Note - Embedded Derivative - settled with Exchange Note" } } }, "auth_ref": [] }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability", "terseLabel": "Fair value of the embedded derivative at issuance", "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability." } } }, "auth_ref": [ "r56" ] }, "dhacu_EmergingGrowthCompanyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EmergingGrowthCompanyPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Represents the accounting policy on Emerging Growth Company.", "label": "Emerging Growth Company [Policy Text Block]", "terseLabel": "Emerging Growth Company" } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r597" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r597" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r676" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r597" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r674" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r597" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r597" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r597" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r597" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r675" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r121", "r135", "r136", "r137", "r151", "r152", "r153", "r155", "r161", "r163", "r174", "r216", "r217", "r278", "r314", "r315", "r316", "r335", "r336", "r353", "r354", "r355", "r356", "r357", "r358", "r361", "r374", "r375", "r376", "r377", "r378", "r379", "r382", "r455", "r456", "r457", "r472", "r537" ] }, "dhacu_EquityLineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EquityLineOfCreditMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to equity line of credit.", "label": "Equity Line of Credit [Member]", "verboseLabel": "ELOC" } } }, "auth_ref": [] }, "dhacu_EquityPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EquityPurchaseAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to equity purchase agreement.", "label": "Equity Purchase Agreement [Member]", "terseLabel": "Equity Purchase Agreement" } } }, "auth_ref": [] }, "dhacu_EquityPurchaseCommitmentNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "EquityPurchaseCommitmentNoteMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for equity purchase commitment note.", "label": "Equity Purchase Commitment Note [Member]", "terseLabel": "Equity Purchase Commitment Note" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r642" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r605", "r617", "r627", "r653" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r602", "r614", "r624", "r650" ] }, "dhacu_ExchangeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExchangeNotesMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to exchange notes.", "label": "Exchange Note [Member]", "terseLabel": "Exchange Note" } } }, "auth_ref": [] }, "dhacu_ExciseTaxOnRedemptionOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExciseTaxOnRedemptionOfCommonStock", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of excise tax related to redemption of common stock.", "label": "Excise Tax On Redemption Of Common Stock", "terseLabel": "Excise tax attributable to redemption of common stock" } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r648" ] }, "dhacu_ExerciseOfWarrantsFractionalSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExerciseOfWarrantsFractionalSharesIssued", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of fractional shares of common stock issued upon exercise of the warrants.", "label": "Exercise Of Warrants, Fractional Shares Issued", "terseLabel": "Fractional shares issued" } } }, "auth_ref": [] }, "dhacu_ExercisePriceOfStockOptions": { "xbrltype": "decimalItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExercisePriceOfStockOptions", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The exercise price of stock options.", "label": "Exercise Price of Stock Options", "terseLabel": "Exercise price of stock options" } } }, "auth_ref": [] }, "dhacu_ExtensionFeeForEachAdditionalThreeMonthsExtensionPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionFeeForEachAdditionalThreeMonthsExtensionPeriod", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Extension fee for each additional three months extension period", "label": "Extension Fee for Each Additional Three Months Extension Period", "terseLabel": "Extension fee" } } }, "auth_ref": [] }, "dhacu_ExtensionFeeIfFormS4RegistrationStatementIsFiled": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionFeeIfFormS4RegistrationStatementIsFiled", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Extension fee if DHAC has filed a Form S-4 registration statement in connection with its initial business combination.", "label": "Extension Fee if Form S-4 Registration Statement is Filed", "terseLabel": "Extension fee in case of Form S-4 Registration statement" } } }, "auth_ref": [] }, "dhacu_ExtensionFeePayableBySponsor": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionFeePayableBySponsor", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of extension fee payable by sponsor.", "label": "Extension Fee Payable by Sponsor", "terseLabel": "Extension fee payable by Sponsor" } } }, "auth_ref": [] }, "dhacu_ExtensionNoteBifurcatedDerivativeMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionNoteBifurcatedDerivativeMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Extension note bifurcated derivative.", "label": "Extension Note Bifurcated Derivative [Member]", "terseLabel": "Extension Note - Bifurcated Derivative" } } }, "auth_ref": [] }, "dhacu_ExtensionNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionNoteMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Extension Note.", "label": "Extension Note [Member]", "terseLabel": "Extension Note" } } }, "auth_ref": [] }, "dhacu_ExtensionNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionNotesMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to extension notes.", "label": "Extension Notes [Member]", "terseLabel": "Extension Notes" } } }, "auth_ref": [] }, "dhacu_ExtensionPeriod": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionPeriod", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the extension period.", "label": "Extension Period", "terseLabel": "Extension period (in months)" } } }, "auth_ref": [] }, "dhacu_ExtensionPeriodToConsummateBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionPeriodToConsummateBusinessCombination", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The extension period to consummate a business combination.", "label": "Extension Period to Consummate a Business Combination", "terseLabel": "Extension period to consummate a business combination" } } }, "auth_ref": [] }, "dhacu_ExtensionPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionPurchaseAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for Extension Purchase Agreement.", "label": "Extension Purchase Agreement [Member]", "terseLabel": "Extension purchase agreement" } } }, "auth_ref": [] }, "dhacu_ExtensionSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionSharesMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for extension shares.", "label": "Extension Shares [Member]", "terseLabel": "Extension Shares" } } }, "auth_ref": [] }, "dhacu_ExtensionWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ExtensionWarrantsMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for Bridge Warrants.", "label": "Extension Warrants [Member]", "terseLabel": "Extension Warrants" } } }, "auth_ref": [] }, "dhacu_FairValueAdjustmentOfNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "FairValueAdjustmentOfNotes", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 5.0 }, "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of notes.", "label": "Fair Value Adjustment Of Notes", "negatedLabel": "Change in fair value", "terseLabel": "Change in fair value" } } }, "auth_ref": [] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 4.0 }, "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of Bifurcated Derivative", "terseLabel": "Change in fair value of Bifurcated Derivative", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r1", "r7" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "FAIR VALUE MEASUREMENTS", "verboseLabel": "FAIR VALUE MEASUREMENTS", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r365", "r366", "r371" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r365", "r366", "r371" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "terseLabel": "Unobservable inputs", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r9" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r249", "r280", "r281", "r282", "r283", "r284", "r285", "r366", "r397", "r398", "r399", "r570", "r571", "r575", "r576", "r577" ] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r59", "r101" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENTS" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurements" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE MEASUREMENTS", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r364" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r249", "r280", "r285", "r366", "r397", "r575", "r576", "r577" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r249", "r280", "r281", "r282", "r283", "r284", "r285", "r366", "r399", "r570", "r571", "r575", "r576", "r577" ] }, "dhacu_FairValueLiabilitiesLevel1ToLevel2TransferAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "FairValueLiabilitiesLevel1ToLevel2TransferAmount", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.", "label": "Fair Value Liabilities Level 1 To Level 2 Transfer Amount", "terseLabel": "Transfers between Level 1 and Level 2" } } }, "auth_ref": [] }, "dhacu_FairValueLiabilitiesLevel2ToLevel1TransferAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "FairValueLiabilitiesLevel2ToLevel1TransferAmount", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of transfers of liabilities measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.", "label": "Fair Value Liabilities Level 2 To Level 1 Transfer Amount", "terseLabel": "Transfers between Level 2 and Level 1" } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of fair value information on recurring basis", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r57", "r102" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r10" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "FAIR VALUE MEASUREMENTS", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3." } } }, "auth_ref": [ "r10", "r59" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of changes in the fair value of the financial liabilities", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r10", "r59" ] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurement", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3", "terseLabel": "Transfers in of level 3", "documentation": "Amount of transfers of financial instrument classified as a liability into level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r370" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3", "terseLabel": "Transfers Out of level 3", "documentation": "Amount of transfers of financial instrument classified as a liability out of level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r370" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "verboseLabel": "Change in valuation inputs or other assumptions", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r369" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "verboseLabel": "Initial value", "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r58" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales", "terseLabel": "Derecognized value at termination date", "documentation": "Amount of sales of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r58" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Fair value as of ending", "periodStartLabel": "Fair value as of beginning", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r10" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r249", "r280", "r281", "r282", "r283", "r284", "r285", "r397", "r398", "r399", "r570", "r571", "r575", "r576", "r577" ] }, "dhacu_FairValueOfBifurcatedDerivative": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "FairValueOfBifurcatedDerivative", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Of Bifurcated Derivative", "verboseLabel": "Fair Value" } } }, "auth_ref": [] }, "dhacu_FairValueOfDerivativeWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "FairValueOfDerivativeWarrants", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Of Derivative Warrants", "terseLabel": "Fair value of PIPE Forward Contract" } } }, "auth_ref": [] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which net income is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r369" ] }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Federal Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Federal" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r257", "r274", "r359", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r451", "r568", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r718", "r719", "r720", "r721" ] }, "dhacu_FinancialInstrumentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "FinancialInstrumentsPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for financial instruments.", "label": "Financial Instruments [Policy Text Block]", "terseLabel": "Financial Instruments" } } }, "auth_ref": [] }, "dhacu_FinancingCostsIncludedInNote": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "FinancingCostsIncludedInNote", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The amount of financing costs included in note.", "label": "Financing Costs Included in Note", "verboseLabel": "Financing costs included in Extension Note" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r609", "r621", "r631", "r657" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r609", "r621", "r631", "r657" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r609", "r621", "r631", "r657" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r609", "r621", "r631", "r657" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r609", "r621", "r631", "r657" ] }, "dhacu_FounderSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "FounderSharesMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for founder shares.", "label": "Founder Shares [Member]", "terseLabel": "Founder shares" } } }, "auth_ref": [] }, "dhacu_GainOnFairValueOfNote": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "GainOnFairValueOfNote", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 }, "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Amount of income related to initial fair value of notes.", "label": "Gain On Fair Value Of Note", "negatedLabel": "Initial gain on fair value of Additional Bridge Note", "terseLabel": "Initial fair value of Additional Bridge Note" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmountAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity [Abstract]", "terseLabel": "FAIR VALUE MEASUREMENTS" } } }, "auth_ref": [] }, "us-gaap_HeldToMaturitySecuritiesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesFairValue", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails": { "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Fair Value", "verboseLabel": "Fair Value", "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r110", "r207", "r438", "r441" ] }, "us-gaap_HeldToMaturitySecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HeldToMaturitySecuritiesTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity [Table Text Block]", "terseLabel": "Schedule of gross holding loss and fair value of held-to-maturity securities", "documentation": "Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity)." } } }, "auth_ref": [ "r700", "r701", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717" ] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IPOMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" ], "lang": { "en-us": { "role": { "label": "IPO [Member]", "terseLabel": "IPO", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r599", "r600", "r613" ] }, "dhacu_IdocMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "IdocMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Idoc.", "label": "iDoc", "terseLabel": "iDoc" } } }, "auth_ref": [] }, "dhacu_IdocNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "IdocNoteMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to iDoc Note.", "label": "iDoc Note [Member]", "terseLabel": "iDoc Note" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before provision for income taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r79", "r108", "r177", "r180", "r182", "r184", "r440", "r448", "r566" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "INCOME TAX" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTax" ], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "terseLabel": "INCOME TAX", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r145", "r318", "r324", "r327", "r333", "r337", "r340", "r341", "r342", "r467" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 1.0 }, "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetailsImported": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "negatedLabel": "Provision for income taxes", "totalLabel": "Income tax provision", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r111", "r118", "r162", "r163", "r179", "r322", "r338", "r453" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r134", "r320", "r321", "r327", "r328", "r332", "r334", "r461" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Income Taxes Payable", "terseLabel": "Income taxes payable", "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction." } } }, "auth_ref": [ "r6" ] }, "dhacu_IncreaseDecreaseInDefaultInterestOnNote": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "IncreaseDecreaseInDefaultInterestOnNote", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the default interest on Note.", "label": "Increase (Decrease) In Default Interest On Note", "terseLabel": "Default interest on Bridge Note" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInterestPayableNet", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Accrued interest", "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid and other current assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "verboseLabel": "Increase (Decrease) in Stockholders' Equity", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "dhacu_IncreasesToTemporaryEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "IncreasesToTemporaryEquityAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Increases To Temporary Equity [Abstract]", "terseLabel": "Plus:" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r612", "r621", "r631", "r648", "r657", "r661", "r669" ] }, "dhacu_InflationReductionActPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "InflationReductionActPolicyPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Represents the accounting policy on inflation reduction act.", "label": "Inflation Reduction Act Policy [Policy Text Block]", "terseLabel": "Inflation Reduction Act of 2022" } } }, "auth_ref": [] }, "dhacu_InitialFairValueGainLossAndChangeInFairValueOfOnLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "InitialFairValueGainLossAndChangeInFairValueOfOnLineOfCredit", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The initial fair value gain or loss and change in fair value of line of credit during the period.", "label": "Initial Fair Value Gain (Loss) And Change In Fair Value of on Line Of Credit", "negatedLabel": "Initial loss on and change in fair value of ELOC" } } }, "auth_ref": [] }, "dhacu_InitialFairValueGainLossOnLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "InitialFairValueGainLossOnLineOfCredit", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "The initial fair value gain or loss on line of credit during the period.", "label": "Initial Fair Value Gain (Loss) on Line Of Credit", "terseLabel": "Initial fair value of ELOC" } } }, "auth_ref": [] }, "dhacu_InitialPublicOfferingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "InitialPublicOfferingAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "INITIAL PUBLIC OFFERING" } } }, "auth_ref": [] }, "dhacu_InitialPublicOfferingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "InitialPublicOfferingLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Initial Public Offering [Line Items]", "terseLabel": "INITIAL PUBLIC OFFERING" } } }, "auth_ref": [] }, "dhacu_InitialPublicOfferingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "InitialPublicOfferingTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOffering" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about initial public offering.", "label": "Initial Public Offering [Text Block]", "terseLabel": "INITIAL PUBLIC OFFERING" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r667" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r601", "r673" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r601", "r673" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r601", "r673" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Debt", "netLabel": "Interest expense", "terseLabel": "Interest expenses- Bridge Note", "verboseLabel": "Interest expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r84", "r254", "r260", "r572", "r573" ] }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebtExcludingAmortization", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Accrued interest", "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs." } } }, "auth_ref": [ "r85", "r255", "r572", "r573" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Interest Payable, Current", "terseLabel": "Accrued interest on Exchange Note", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r16" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 }, "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Investment Income, Interest", "negatedLabel": "Interest earned on investments held in Trust Account", "terseLabel": "Interest earned on investments held in Trust Account", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r82", "r178" ] }, "dhacu_InvestorNoteWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "InvestorNoteWarrantsMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to investor note warrants.", "label": "Investor Note Warrants [Member]", "terseLabel": "Investor Note Warrants" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LegalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LegalFees", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Legal Fees", "terseLabel": "Legal fee", "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings." } } }, "auth_ref": [ "r81" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r15", "r144", "r215", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r348", "r351", "r352", "r373", "r492", "r565", "r595", "r725", "r767", "r768" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r78", "r107", "r447", "r583", "r693", "r722", "r765" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r17", "r124", "r144", "r215", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r348", "r351", "r352", "r373", "r583", "r725", "r767", "r768" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "auth_ref": [] }, "us-gaap_LinesOfCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LinesOfCreditCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Line of Credit, Current", "terseLabel": "Line of credit", "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r69", "r104" ] }, "dhacu_LiquidityAndGoingConcernPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "LiquidityAndGoingConcernPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for liquidity and going concern.", "label": "Liquidity and Going Concern [Policy Text Block]", "terseLabel": "Liquidity and Going Concern" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "terseLabel": "Amount net of unamortized debt discount", "verboseLabel": "Notes payable net of unamortized debt discount", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r12", "r106", "r248", "r259", "r570", "r571", "r775" ] }, "dhacu_MaximumAllowedDissolutionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MaximumAllowedDissolutionExpenses", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period.", "label": "Maximum Allowed Dissolution Expenses", "terseLabel": "Maximum allowed dissolution expenses" } } }, "auth_ref": [] }, "dhacu_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of maximum borrowing capacity of related party promissory note.", "label": "Maximum Borrowing Capacity of Related Party Promissory Note", "terseLabel": "Maximum borrowing capacity of related party promissory note" } } }, "auth_ref": [] }, "dhacu_MaximumCalendarYearDaysForSuspensionForUseOfResaleRegistrationStatement": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MaximumCalendarYearDaysForSuspensionForUseOfResaleRegistrationStatement", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum calendar year days for suspension for use of resale registration statement.", "label": "Maximum Calendar Year Days For Suspension For Use Of Resale Registration Statement", "terseLabel": "Maximum calendar year days for suspension for use of resale registration statement" } } }, "auth_ref": [] }, "dhacu_MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum consecutive days for suspension for use of resale registration statement.", "label": "Maximum Consecutive Days For Suspension For Use Of Resale Registration Statement", "terseLabel": "Maximum consecutive days for suspension for use of resale registration statement" } } }, "auth_ref": [] }, "dhacu_MaximumExtensionPeriodToConsummateBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MaximumExtensionPeriodToConsummateBusinessCombination", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum extension period to consummate a business combination.", "label": "Maximum Extension Period to Consummate a Business Combination", "terseLabel": "Aggregate extension period to consummate a business combination" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "auth_ref": [ "r228", "r229", "r230", "r231", "r287", "r424", "r454", "r484", "r485", "r545", "r546", "r547", "r548", "r549", "r557", "r558", "r567", "r574", "r580", "r584", "r727", "r769", "r770", "r771", "r772", "r773", "r774" ] }, "dhacu_MaximumNumberOfDemandsForRegistrationOfSecurities": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MaximumNumberOfDemandsForRegistrationOfSecurities", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the maximum number of demands for registration of securities.", "label": "Maximum Number Of Demands For Registration Of Securities" } } }, "auth_ref": [] }, "dhacu_MaximumValueOfSharesAgreedToBeIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MaximumValueOfSharesAgreedToBeIssued", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum value of shares agreed to be issued.", "label": "Maximum Value Of Shares Agreed To Be Issued", "terseLabel": "Maximum amount of shares issuable" } } }, "auth_ref": [] }, "dhacu_MaximumValueOfSharesAgreedToBePurchased": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MaximumValueOfSharesAgreedToBePurchased", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum value fo shares agreed to be purchased.", "label": "Maximum Value Of Shares Agreed To Be Purchased", "terseLabel": "Maximum value of shares agreed to be purchased" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r640" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r640" ] }, "dhacu_MeasurementInputCccBondRateMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MeasurementInputCccBondRateMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using CCC bond rates.", "label": "Measurement Input, CCC Bond Rate [Member]", "terseLabel": "CCC bond rates" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "label": "Expected life of the options to convert", "terseLabel": "Expected term (years)", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r763" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails" ], "lang": { "en-us": { "role": { "label": "Volatility", "terseLabel": "Volatility", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r763" ] }, "dhacu_MeasurementInputProbabilityOfCompletingBusinessCombinationByPeriodFourMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MeasurementInputProbabilityOfCompletingBusinessCombinationByPeriodFourMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using probability of completing a business combination by period four.", "label": "Measurement Input, Probability Of Completing Business Combination by Period Four [Member]", "terseLabel": "Probability of completing a business combination by March 31, 2024" } } }, "auth_ref": [] }, "dhacu_MeasurementInputProbabilityOfCompletingBusinessCombinationByPeriodOneMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MeasurementInputProbabilityOfCompletingBusinessCombinationByPeriodOneMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using probability of completing a business combination by period one.", "label": "Measurement Input, Probability Of Completing Business Combination by Period One [Member]", "terseLabel": "Probability of completing a business combination by March 31, 2023", "verboseLabel": "Probability of completing a business combination by August 30, 2023" } } }, "auth_ref": [] }, "dhacu_MeasurementInputProbabilityOfCompletingBusinessCombinationByPeriodTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MeasurementInputProbabilityOfCompletingBusinessCombinationByPeriodTwoMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using probability of completing a business combination by period two.", "label": "Measurement Input, Probability Of Completing Business Combination by Period Two [Member]", "terseLabel": "Probability of completing a business combination by June 30, 2023", "verboseLabel": "Probability of completing a business combination by September 30, 2023" } } }, "auth_ref": [] }, "dhacu_MeasurementInputProbabilityOfCompletingBusinessCombinationMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MeasurementInputProbabilityOfCompletingBusinessCombinationMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using probability of completing a Business Combination.", "label": "Probability of completing a Business Combination", "terseLabel": "Probability of completing a business combination" } } }, "auth_ref": [] }, "dhacu_MeasurementInputProbabilityOfEarlyTerminationRepaymentBusinessCombinationCompletedOrPipeCompletedMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MeasurementInputProbabilityOfEarlyTerminationRepaymentBusinessCombinationCompletedOrPipeCompletedMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using probability of early termination/repayment, business combination completed, or PIPE completed.", "label": "Measurement Input, Probability Of Early Termination/Repayment, Business Combination Completed, Or Pipe Completed [Member]", "terseLabel": "Probability of early termination/repayment - business combination completed, or PIPE completed" } } }, "auth_ref": [] }, "dhacu_MeasurementInputProbabilityOfEarlyTerminationRepaymentBusinessCombinationNotCompletedMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MeasurementInputProbabilityOfEarlyTerminationRepaymentBusinessCombinationNotCompletedMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using probability of early termination/repayment, business combination not completed.", "label": "Measurement Input, Probability Of Early Termination/Repayment, Business Combination Not Completed [Member]", "terseLabel": "Probability of early termination/repayment - business combination not completed" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "label": "Risk-free rate", "terseLabel": "Risk-free interest rate", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r763" ] }, "us-gaap_MeasurementInputSharePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputSharePriceMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Share Price [Member]", "terseLabel": "Stock price", "documentation": "Measurement input using share price of saleable stock." } } }, "auth_ref": [ "r763" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r367" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForAdditionalBridgeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForBridgeNoteBifurcateDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForElocEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExchangeNoteDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForExtensionNoteBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "dhacu_MinimumAggregatePipeProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MinimumAggregatePipeProceeds", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum aggregate PIPE proceeds from PIPE financing.", "label": "Minimum Aggregate PIPE Proceeds", "terseLabel": "Aggregate closing PIPE proceeds" } } }, "auth_ref": [] }, "dhacu_MinimumAggregatePurchasePriceOfAdditionalOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MinimumAggregatePurchasePriceOfAdditionalOffering", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum aggregate purchase price of additional offering under PIPE financing.", "label": "Minimum Aggregate Purchase Price of Additional Offering", "terseLabel": "Minimum aggregate purchase price of additional offering" } } }, "auth_ref": [] }, "dhacu_MinimumGrossProceedsOfNotesToBePaidInCashForConsummationOfSubsequentPlacements": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MinimumGrossProceedsOfNotesToBePaidInCashForConsummationOfSubsequentPlacements", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of minimum gross proceeds of Notes to be paid in cash for consummation of subsequent placements.", "label": "Minimum Gross Proceeds of Notes to be Paid In Cash for the Consummation of Subsequent Placements", "terseLabel": "Minimum gross proceeds of Notes to be paid in cash for consummation of subsequent placements" } } }, "auth_ref": [] }, "dhacu_MinimumMarketValueOfListedSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MinimumMarketValueOfListedSecurities", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum amount of market value of listed securities.", "label": "Minimum Market Value Of Listed Securities", "terseLabel": "Minimum market value of listed securities" } } }, "auth_ref": [] }, "dhacu_MinimumNoticePeriodForRedemptionOfNotes": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MinimumNoticePeriodForRedemptionOfNotes", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum notice period for redemption of notes.", "label": "Minimum Notice Period For Redemption Of Notes", "terseLabel": "Minimum notice period for redemption of notes" } } }, "auth_ref": [] }, "dhacu_MinimumPercentageOfIncreaseOrDecreaseInAggregateNumberOfShares": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MinimumPercentageOfIncreaseOrDecreaseInAggregateNumberOfShares", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the minimum percentage of increase or decrease in aggregate number of shares of Common Stock purchasable upon exercise of all Bridge Warrants for adjustment in the number of shares of Common Stock receivable upon exercise of the Bridge Warrant.", "label": "Minimum Percentage Of Increase Or Decrease In Aggregate Number Of Shares", "terseLabel": "Minimum percentage of increase or decrease in in aggregate number of shares of Common Stock purchasable upon exercise of all Bridge Warrants for adjustment in the number of shares of Common Stock receivable upon exercise of the Bridge Warrant" } } }, "auth_ref": [] }, "dhacu_MinimumPercentageOfSharesIssuableUponConversionOfPipeSharesAndWarrants": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MinimumPercentageOfSharesIssuableUponConversionOfPipeSharesAndWarrants", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This concept represents percentage of shares issuable upon conversion of PIPE shares and warrants.", "label": "Minimum Percentage of Shares Issuable Upon Conversion of PIPE Shares and Warrants", "terseLabel": "Minimum percentage of shares issuable upon conversion of PIPE shares and warrants" } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r660" ] }, "us-gaap_MoneyMarketFundsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MoneyMarketFundsMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds", "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities." } } }, "auth_ref": [ "r730" ] }, "dhacu_MonthsToCompleteAcquisitionPeriod": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "MonthsToCompleteAcquisitionPeriod", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the anticipated business time line in months for completing a business combination.", "label": "Months To Complete an Acquisition Period", "terseLabel": "Months to complete acquisition" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r668" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r641" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperations" ], "lang": { "en-us": { "role": { "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [TEXT BLOCK]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r112", "r119" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r140" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r140" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r86", "r87", "r88" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCalculationOfBasicAndDilutedNetLossPerCommonStockDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "verboseLabel": "Allocation of net loss", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r80", "r88", "r109", "r122", "r132", "r133", "r137", "r144", "r154", "r156", "r157", "r158", "r159", "r162", "r163", "r168", "r177", "r180", "r182", "r184", "r215", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r363", "r373", "r450", "r514", "r535", "r536", "r566", "r593", "r725" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCalculationOfBasicAndDilutedNetLossPerCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]", "terseLabel": "Numerator:" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r640" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r609", "r621", "r631", "r648", "r657" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r638" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r637" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r648" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r668" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r668" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense)", "totalLabel": "Total other (expense) income", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r83" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other (expense) income:" } } }, "auth_ref": [] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Notes Payable, Current", "terseLabel": "Notes payable current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r14" ] }, "dhacu_NumberOfAdditionalThreeMonthExtensionsToConsummateBusinessCombination": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfAdditionalThreeMonthExtensionsToConsummateBusinessCombination", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of additional three-month extensions permitted to consummate Business Combinations.", "label": "Number of Additional Three Month Extensions to Consummate Business Combination", "terseLabel": "Number of extensions permitted" } } }, "auth_ref": [] }, "dhacu_NumberOfExtensionsToConsummateBusinessCombination": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfExtensionsToConsummateBusinessCombination", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of extensions to consummate a business combination.", "label": "Number of Extensions to Consummate a Business Combination", "terseLabel": "Number of extensions to consummate a business combination" } } }, "auth_ref": [] }, "dhacu_NumberOfInstrumentsForWhichRelativeFairValueBasisUsed": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfInstrumentsForWhichRelativeFairValueBasisUsed", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of instruments for which relative fair value basis used.", "label": "Number of Instruments for Which Relative Fair Value Basis Used", "terseLabel": "Number of instruments for which relative fair value basis used" } } }, "auth_ref": [] }, "dhacu_NumberOfSharesIssuedAsPartOfCommitment": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfSharesIssuedAsPartOfCommitment", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued as part of commitment.", "label": "Number of Shares Issued as Part of Commitment", "terseLabel": "Shares issued as part of commitment" } } }, "auth_ref": [] }, "dhacu_NumberOfSharesIssuedPerUnit": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfSharesIssuedPerUnit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares in a unit.", "label": "Number of Shares Issued Per Unit", "terseLabel": "Number of shares in a unit" } } }, "auth_ref": [] }, "dhacu_NumberOfSharesSubjectToForfeiture": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfSharesSubjectToForfeiture", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.", "label": "Number Of Shares Subject To Forfeiture", "terseLabel": "Shares subject to forfeiture" } } }, "auth_ref": [] }, "dhacu_NumberOfSharesToBeIssued": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfSharesToBeIssued", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of shares to be issued under agreement.", "label": "Number of Shares to be Issued", "terseLabel": "Number of shares to be issued" } } }, "auth_ref": [] }, "dhacu_NumberOfWarrantsExercisableForCash": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfWarrantsExercisableForCash", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of warrants exercisable for cash.", "label": "Number Of Warrants Exercisable For Cash", "terseLabel": "Warrants exercisable for cash" } } }, "auth_ref": [] }, "dhacu_NumberOfWarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfWarrantsIssued", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of warrants issued.", "label": "Number Of Warrants Issued", "terseLabel": "Number of warrants issued", "verboseLabel": "Issuance of 173,913 warrants issued with Bridge Note, net of offering cost" } } }, "auth_ref": [] }, "dhacu_NumberOfWarrantsIssuedPerUnit": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "NumberOfWarrantsIssuedPerUnit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of warrants in a unit.", "label": "Number of Warrants Issued Per Unit", "terseLabel": "Number of warrants in a unit" } } }, "auth_ref": [] }, "dhacu_OfferingCostAllocatedToShares": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "OfferingCostAllocatedToShares", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering cost allocated to shares.", "label": "Offering Cost Allocated to Shares", "terseLabel": "Offering cost allocated to shares" } } }, "auth_ref": [] }, "dhacu_OfferingCostAllocatedToWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "OfferingCostAllocatedToWarrants", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering cost allocated to warrants.", "label": "Offering Cost Allocated to Warrants", "terseLabel": "Offering cost allocated to warrants" } } }, "auth_ref": [] }, "dhacu_OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of offering costs associated with the initial public offering.", "label": "Offering Costs Associated With The Initial Public Offering [Policy Text Block]", "terseLabel": "Offering Costs" } } }, "auth_ref": [] }, "us-gaap_OperatingCostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingCostsAndExpenses", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Costs and Expenses", "terseLabel": "Formation and operational costs", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Loss from operations", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r177", "r180", "r182", "r184", "r566" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r49" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS" } } }, "auth_ref": [] }, "dhacu_OriginalIssuedDiscountExpensesAsInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "OriginalIssuedDiscountExpensesAsInterest", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of original issued discount expensed as interest.", "label": "Original Issued Discount Expenses as Interest", "terseLabel": "Original issued discount expensed" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Liabilities, Current", "terseLabel": "Advances from related parties", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r16", "r583" ] }, "us-gaap_OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Liability, Current, Related Party, Type [Extensible Enumeration]", "documentation": "Indicates type of related party for liability classified as other and current." } } }, "auth_ref": [ "r766" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r640" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r607", "r619", "r629", "r655" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r610", "r622", "r632", "r658" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r610", "r622", "r632", "r658" ] }, "us-gaap_OverAllotmentOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OverAllotmentOptionMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" ], "lang": { "en-us": { "role": { "label": "Over-Allotment Option [Member]", "terseLabel": "Over-allotment option", "documentation": "Right given to the underwriter to sell additional shares over the initial allotment." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r636" ] }, "dhacu_PaymentsForInvestmentOfCashInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PaymentsForInvestmentOfCashInTrustAccount", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash outflow for investment of cash in trust account.", "label": "Payments For Investment Of Cash In Trust Account", "negatedLabel": "Investment of cash into Trust Account", "terseLabel": "Investment of cash into trust account" } } }, "auth_ref": [] }, "dhacu_PaymentsForOptionalPrepaymentAsPercentageOfOutstandingObligation": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PaymentsForOptionalPrepaymentAsPercentageOfOutstandingObligation", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the payments for optional prepayment as percentage of outstanding obligation.", "label": "Payments For Optional Prepayment As Percentage Of Outstanding Obligation", "terseLabel": "Payments for optional prepayment as percentage of outstanding obligation" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Redemption of common stock", "terseLabel": "Redemption of common stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r24" ] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "label": "Payments of Debt Issuance Costs", "terseLabel": "Direct cost attributable to the financing", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r26" ] }, "us-gaap_PaymentsOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfFinancingCosts", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of Financing Costs", "negatedLabel": "Payment of Financing Cost in Bridge Note", "terseLabel": "Amount of direct cost attributable to the financing", "documentation": "The cash outflow for loan and debt issuance costs." } } }, "auth_ref": [ "r23" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r639" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r639" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r638" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r648" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r641" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r637" ] }, "dhacu_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.", "label": "Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination", "terseLabel": "Obligation to redeem public shares if entity does not complete a Business Combination (as a percent)" } } }, "auth_ref": [] }, "dhacu_PercentageOfCommonStockIssuedAsConsideration": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PercentageOfCommonStockIssuedAsConsideration", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of common stock issued as consideration.", "label": "Percentage of Common Stock Issued as Consideration", "terseLabel": "Percentage of common stock issued as consideration" } } }, "auth_ref": [] }, "dhacu_PercentageOfCommonStockSharesToBeRedeemedOrRepurchasedUponFailureToConsummateBusinessCombination": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PercentageOfCommonStockSharesToBeRedeemedOrRepurchasedUponFailureToConsummateBusinessCombination", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "The percentage of common stock shares to be redeemed or repurchased upon failure to consummate business combination.", "label": "Percentage Of Common Stock Shares To Be Redeemed Or Repurchased Upon Failure To Consummate Business Combination", "terseLabel": "Percentage of common stock shares to be redeemed or repurchased upon failure to consummate business combination" } } }, "auth_ref": [] }, "dhacu_PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant": { "xbrltype": "pureItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PercentageOfGrossNewProceedsToTotalEquityProceedsUsedToMeasureDilutionOfWarrant", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The ratio of gross proceeds from a future offering to total equity proceeds which is used to measure whether dilution of the warrant has occurred. If aggregate gross proceeds from a new offering exceeds a specified percentage of total equity proceeds, the warrant exercise price will be adjusted.", "label": "Percentage Of Gross New Proceeds To Total Equity Proceeds Used To Measure Dilution Of Warrant", "terseLabel": "Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant" } } }, "auth_ref": [] }, "dhacu_PercentageOfGuaranteedInterestDueAndPayableIfPipeFinancingClosedAtClosingOfBusinessCombination": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PercentageOfGuaranteedInterestDueAndPayableIfPipeFinancingClosedAtClosingOfBusinessCombination", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of guaranteed interest is due and payable at the closing of the PIPE Financing.", "label": "Percentage of Guaranteed Interest Due and Payable, If PIPE financing Closed at Closing of Business Combination", "terseLabel": "Percentage of unpaid principal due and payable if PIPE Financing closes in connection with the closing of the Business Combination" } } }, "auth_ref": [] }, "dhacu_PercentageOfOriginalIssueDiscount": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PercentageOfOriginalIssueDiscount", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of original issue discount.", "label": "Percentage Of Original Issue Discount", "terseLabel": "Original issue discount (in percent)" } } }, "auth_ref": [] }, "dhacu_PercentageOfUnpaidPrincipalDueAndPayableIfPipeFinancingClosedAtClosingOfBusinessCombination": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PercentageOfUnpaidPrincipalDueAndPayableIfPipeFinancingClosedAtClosingOfBusinessCombination", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of unpaid principal under the Bridge Notes is due and payable at the closing of the PIPE Financing.", "label": "Percentage of Unpaid Principal Due and Payable, If PIPE financing Closed at Closing of Business Combination", "terseLabel": "Percentage of unpaid principal due and payable if PIPE Financing closes in connection with the closing of the Business Combination" } } }, "auth_ref": [] }, "dhacu_PeriodAgreedToFileResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PeriodAgreedToFileResaleRegistrationStatement", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period agreed to file a resale registration statement.", "label": "Period Agreed To File Resale Registration Statement", "terseLabel": "Period agreed to file a resale registration statement (in days)" } } }, "auth_ref": [] }, "dhacu_PeriodWithinWhichRegistrationStatementShallBeDeclaredEffective": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PeriodWithinWhichRegistrationStatementShallBeDeclaredEffective", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the period within which registration statement shall be declared effective.", "label": "Period Within Which Registration Statement Shall Be Declared Effective", "terseLabel": "Period within which registration statement shall be declared effective (in days)" } } }, "auth_ref": [] }, "dhacu_PipeForwardContractDerivative": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PipeForwardContractDerivative", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsFairValueInformationOnRecurringBasisDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "The amount of pipe forward contract derivative.", "label": "Pipe Forward Contract Derivative", "terseLabel": "PIPE Forward Contract" } } }, "auth_ref": [] }, "dhacu_PipeForwardContractMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PipeForwardContractMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsChangesInFairValueOfFinancialLiabilitiesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to pipe forward contract.", "label": "Pipe Forward Contract [Member]", "terseLabel": "PIPE Forward Contract", "verboseLabel": "Forward Contract" } } }, "auth_ref": [] }, "dhacu_PipeInvestorsMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PipeInvestorsMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to PIPE investors.", "label": "PIPE Investors [Member]", "terseLabel": "PIPE Investors" } } }, "auth_ref": [] }, "dhacu_PipeRegistrationRightsAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PipeRegistrationRightsAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to PIPE registration rights agreement.", "label": "PIPE Registration Rights Agreement [Member]", "terseLabel": "PIPE Registration Rights Agreement" } } }, "auth_ref": [] }, "dhacu_PipeSecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PipeSecuritiesPurchaseAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to pipe securities purchase agreement.", "label": "PIPE Securities Purchase Agreement [Member]", "terseLabel": "PIPE Securities Purchase Agreement" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r731", "r732", "r733", "r734", "r735", "r736", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r754", "r755", "r756" ] }, "dhacu_PreferredStockCommonStockSharesIssuedUponConversion": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PreferredStockCommonStockSharesIssuedUponConversion", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for shares of preferred stock that is converted.", "label": "Preferred Stock, Common Stock Shares Issued Upon Conversion", "terseLabel": "Number of preferred stock converted to into common stock" } } }, "auth_ref": [] }, "dhacu_PrivatePlacementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PrivatePlacementAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "PRIVATE PLACEMENT." } } }, "auth_ref": [] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrivatePlacementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "label": "Private Placement [Member]", "terseLabel": "Private Placement", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "dhacu_PrivatePlacementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PrivatePlacementTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacement" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on information about private placement.", "label": "Private Placement [Text Block]", "terseLabel": "PRIVATE PLACEMENT" } } }, "auth_ref": [] }, "dhacu_PrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PrivatePlacementWarrantsMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.", "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance Initial Public Offering", "verboseLabel": "Proceeds from issuance Initial Public Offering", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSecuredDebt", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Amount of proceeds received", "verboseLabel": "Proceeds from Bridge Note", "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt." } } }, "auth_ref": [ "r22" ] }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfWarrants", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" ], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from sale of private placement warrants", "verboseLabel": "Aggregate purchase price", "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)." } } }, "auth_ref": [ "r5" ] }, "dhacu_ProceedsFromIssuanceOfWarrantsIncludedInSubscriptionReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ProceedsFromIssuanceOfWarrantsIncludedInSubscriptionReceivable", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" ], "lang": { "en-us": { "role": { "documentation": "The recorded receivable from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants, Included in Subscription Receivable", "terseLabel": "Receivable recorded from the sale of private placement warrants", "verboseLabel": "Aggregate purchase price" } } }, "auth_ref": [] }, "dhacu_ProceedsFromM2bNote": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ProceedsFromM2bNote", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow from amounts received from M2B note.", "label": "Proceeds from M2B Note", "terseLabel": "Proceeds from M2B Note" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Notes Payable", "terseLabel": "Proceeds from notes payable", "verboseLabel": "Cash proceeds from issuance of notes", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r22" ] }, "dhacu_ProceedsFromRelatedPartyAsAdvances": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ProceedsFromRelatedPartyAsAdvances", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of advances from related party during the period.", "label": "Proceeds from Related Party as Advances", "terseLabel": "Advances from related party" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from promissory note - related party", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r22" ] }, "dhacu_ProceedsFromTrustAccountInConnectionWithRedemptions": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ProceedsFromTrustAccountInConnectionWithRedemptions", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash in-flow for proceeds from Trust Account in connection with redemptions.", "label": "Proceeds from Trust Account in Connection with Redemptions", "terseLabel": "Cash withdrawn from Trust Account in connection with redemptions" } } }, "auth_ref": [] }, "dhacu_ProceedsHeldInTrustAccountUsedToRepayWorkingCapitalLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ProceedsHeldInTrustAccountUsedToRepayWorkingCapitalLoans", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of proceeds held in trust account used to repay working capital loans .", "label": "Proceeds Held in Trust Account Used to Repay Working Capital Loans", "terseLabel": "Proceeds held in trust account used to repay working capital loans" } } }, "auth_ref": [] }, "dhacu_ProceedsOfCashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ProceedsOfCashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes", "crdr": "debit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The amount of proceeds of cash withdrawn from trust account to pay franchise and income taxes.", "label": "Proceeds Of Cash Withdrawn from Trust Account to Pay Franchise and Income Taxes", "terseLabel": "Cash withdrawn from Trust Account to pay franchise and income taxes" } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r122", "r132", "r133", "r139", "r144", "r154", "r162", "r163", "r177", "r180", "r182", "r184", "r215", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r346", "r349", "r350", "r363", "r373", "r440", "r449", "r471", "r514", "r535", "r536", "r566", "r581", "r582", "r594", "r689", "r725" ] }, "dhacu_PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PromissoryNoteMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to promissory note.", "label": "Promissory Note [Member]", "terseLabel": "Promissory note" } } }, "auth_ref": [] }, "dhacu_PromissoryNoteRelatedPartyClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PromissoryNoteRelatedPartyClassifiedCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "The amount represents Promissory note related party classified current.", "label": "Promissory Note Related Party Classified Current", "terseLabel": "Promissory note - related party" } } }, "auth_ref": [] }, "dhacu_PromissoryNoteRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PromissoryNoteRelatedPartyMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to unsecured promissory note to Sponsor.", "label": "Promissory Note Related Party [Member]", "terseLabel": "Unsecured promissory note" } } }, "auth_ref": [] }, "dhacu_PromissoryNoteWithRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PromissoryNoteWithRelatedPartyMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for promissory note with related party.", "label": "Promissory Note with Related Party", "terseLabel": "Promissory Note with Related Party" } } }, "auth_ref": [] }, "dhacu_PromissoryNotesWithM2bFundingCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PromissoryNotesWithM2bFundingCorpMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to promissory notes with M2B funding corp.", "label": "Promissory Notes With M2B Funding Corp [Member]", "terseLabel": "Promissory note - M2B" } } }, "auth_ref": [] }, "dhacu_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "PublicWarrantsMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.", "label": "Public Warrants [Member]", "terseLabel": "Public Warrants" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r636" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r636" ] }, "dhacu_QuantumInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "QuantumInvestorMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for quantum investors.", "label": "Quantum Investor [Member]", "terseLabel": "Quantum Investor" } } }, "auth_ref": [] }, "dhacu_QuantumNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "QuantumNoteMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to quantum notes.", "label": "Quantum Note [Member]", "terseLabel": "Quantum Note" } } }, "auth_ref": [] }, "dhacu_QuantunPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "QuantunPurchaseAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member represents for Quantum Purchase Agreement.", "label": "Quantun Purchase Agreement [Member]", "terseLabel": "Quantum Purchase Agreement" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r228", "r229", "r230", "r231", "r279", "r287", "r310", "r311", "r312", "r400", "r424", "r454", "r484", "r485", "r545", "r546", "r547", "r548", "r549", "r557", "r558", "r567", "r574", "r580", "r584", "r587", "r723", "r727", "r770", "r771", "r772", "r773", "r774" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r228", "r229", "r230", "r231", "r279", "r287", "r310", "r311", "r312", "r400", "r424", "r454", "r484", "r485", "r545", "r546", "r547", "r548", "r549", "r557", "r558", "r567", "r574", "r580", "r584", "r587", "r723", "r727", "r770", "r771", "r772", "r773", "r774" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r602", "r614", "r624", "r650" ] }, "dhacu_RedemptionOfSharesCalculatedBasedOnNumberOfBusinessDaysPriorToConsummationOfBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "RedemptionOfSharesCalculatedBasedOnNumberOfBusinessDaysPriorToConsummationOfBusinessCombination", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the redemption of shares calculated based on number of business days prior to consummation of business combination.", "label": "Redemption of Shares Calculated Based On Number Of Business Days Prior To Consummation Of Business Combination", "terseLabel": "Redemption of shares calculated based on business days prior to consummation of Business Combination (in days)" } } }, "auth_ref": [] }, "dhacu_RedemptionPeriod": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "RedemptionPeriod", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the term of redemption period.", "label": "Redemption Period", "terseLabel": "Redemption period" } } }, "auth_ref": [] }, "dhacu_RedemptionPeriodUponClosure": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "RedemptionPeriodUponClosure", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "documentation": "The period of time in which the reporting entity must redeem shares issued pursuant to the offering.", "label": "Redemption Period Upon Closure", "terseLabel": "Redemption period upon closure" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r286", "r386", "r387", "r487", "r488", "r489", "r490", "r491", "r511", "r513", "r544" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Member]", "terseLabel": "Related party", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r146", "r147", "r386", "r387", "r388", "r389", "r487", "r488", "r489", "r490", "r491", "r511", "r513", "r544" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r386", "r387", "r766" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "dhacu_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The contractual monthly amount to be paid for support services.", "label": "Related Party Transaction, Expenses from Transactions with Related Party Per Month", "terseLabel": "Expenses per month" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "terseLabel": "RELATED PARTY TRANSACTIONS", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r518", "r519", "r522" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsAdditionalBridgeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "label": "Related Party [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r286", "r386", "r387", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r487", "r488", "r489", "r490", "r491", "r511", "r513", "r544", "r766" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r383", "r384", "r385", "r387", "r390", "r468", "r469", "r470", "r520", "r521", "r522", "r541", "r543" ] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of Related Party Debt", "negatedTerseLabel": "Repayment of advances from related party", "terseLabel": "Repayment of promissory note - related party", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r25" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r148", "r149", "r244", "r264", "r389", "r561", "r562" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r603", "r615", "r625", "r651" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r604", "r616", "r626", "r652" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r611", "r623", "r633", "r659" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r75", "r96", "r446", "r458", "r459", "r466", "r495", "r583" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r121", "r151", "r152", "r153", "r155", "r161", "r163", "r216", "r217", "r314", "r315", "r316", "r335", "r336", "r353", "r355", "r356", "r358", "r361", "r455", "r457", "r472", "r780" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r668" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r668" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "dhacu_SaleOfStockOtherOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SaleOfStockOtherOfferingCosts", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails": { "parentTag": "dhacu_TransactionCosts", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of other offering costs incurred.", "label": "Sale of Stock, Other Offering Costs", "terseLabel": "Other offering costs" } } }, "auth_ref": [] }, "dhacu_SaleOfStockUnderwritingFees": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SaleOfStockUnderwritingFees", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails": { "parentTag": "dhacu_TransactionCosts", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of offering fees incurred and paid for underwriters.", "label": "Sale of Stock, Underwriting fees", "terseLabel": "Underwriting fees" } } }, "auth_ref": [] }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesAndExciseTaxPayableCurrent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Excise tax payable", "verboseLabel": "Excise tax", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r13" ] }, "dhacu_ScheduleOfBifurcatedDerivativeRatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ScheduleOfBifurcatedDerivativeRatesTableTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of Bifurcated Derivative Rates.", "label": "Schedule Of Bifurcated Derivative Rates [Table Text Block]", "terseLabel": "Schedule of key inputs into the Monte Carlo simulation model for Bridge Note Bifurcated Derivative" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r50", "r51", "r343" ] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of income tax provision", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r100" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of net deferred tax assets", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r99" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Net Loss per Common Share", "terseLabel": "Schedule of calculation of basic and diluted net loss per common stock", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r699" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]", "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share." } } }, "auth_ref": [ "r32", "r35", "r166", "r167", "r169" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Summary of reconciliation of the federal income tax rate to the Company's effective tax rate", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r98" ] }, "dhacu_ScheduleOfInitialPublicOfferingTable": { "xbrltype": "stringItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ScheduleOfInitialPublicOfferingTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for initial public offering.", "label": "Schedule of Initial Public Offering [Table]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r64", "r65", "r518", "r519", "r522" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of key inputs into the investor note bifurcated derivative, PWERM for the PIPE Forward Contracts, Additional bridge note and exchange note", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r97" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r41", "r42", "r43", "r44", "r45", "r46", "r47", "r94", "r95", "r96", "r127", "r128", "r129", "r175", "r262", "r263", "r264", "r266", "r269", "r274", "r276", "r462", "r463", "r464", "r465", "r574", "r677", "r691" ] }, "dhacu_ScsCapitalPartnersLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ScsCapitalPartnersLlcMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to SCS Capital Partners LLC .", "label": "SCS Capital Partners LLC [Member]", "terseLabel": "SCS Capital Partners LLC" } } }, "auth_ref": [] }, "dhacu_SecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SecuritiesPurchaseAgreementMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to securities purchase agreement.", "label": "Securities Purchase Agreement [Member]", "terseLabel": "Securities Purchase Agreement" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r596" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r598" ] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r687", "r688", "r729" ] }, "us-gaap_SeriesBPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesBPreferredStockMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock", "documentation": "Series B preferred stock." } } }, "auth_ref": [ "r687", "r688", "r729" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313" ] }, "dhacu_SharePriceTriggerForEarlyRedemptionOfNotes": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SharePriceTriggerForEarlyRedemptionOfNotes", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsQuantumFinancingSecuritiesPurchaseAgreementDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the share price trigger for early redemption of notes.", "label": "Share Price Trigger For Early Redemption Of Notes", "terseLabel": "Share price trigger for early redemption of notes" } } }, "auth_ref": [] }, "dhacu_SharePriceTriggerUsedToMeasureDilutionOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SharePriceTriggerUsedToMeasureDilutionOfWarrants", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The cut off price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.", "label": "Share Price Trigger Used To Measure Dilution Of Warrants", "terseLabel": "Share price trigger used to measure dilution of warrant" } } }, "auth_ref": [] }, "dhacu_SharesAgreedToBeIssuedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SharesAgreedToBeIssuedPeriod", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsEquityFinancingDetails" ], "lang": { "en-us": { "role": { "documentation": "Duration over which shares agreed to be issued.", "label": "Shares Agreed To Be Issued Period", "terseLabel": "Term for shares to be issued" } } }, "auth_ref": [] }, "dhacu_SharesAgreedToBePurchasedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SharesAgreedToBePurchasedPeriod", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Duration over which shares agreed to be purchased to be fulfilled.", "label": "Shares Agreed To Be Purchased, Period", "terseLabel": "Period to fulfill shares agreed to be purchased" } } }, "auth_ref": [] }, "dhacu_SharesFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SharesFairValue", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the fair value of shares.", "label": "Shares, Fair Value", "terseLabel": "Fair value of shares" } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Shares, Issued", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r8" ] }, "dhacu_SharesIssuedAndOutstandingEntitledToVote": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SharesIssuedAndOutstandingEntitledToVote", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of remaining shares issued and outstanding entitled to vote.", "label": "Shares Issued and Outstanding Entitled To Vote", "terseLabel": "Number of remaining shares issued and outstanding entitled to vote Number of remaining shares issued and outstanding entitled to vote" } } }, "auth_ref": [] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" ], "lang": { "en-us": { "role": { "label": "Shares Issued, Price Per Share", "terseLabel": "Purchase price, per unit", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "dhacu_SharesSubjectToMandatoryRedemptionDisclosureTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SharesSubjectToMandatoryRedemptionDisclosureTableTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature and terms of the financial instruments and the rights and obligations embodied in those instruments, information about settlement alternatives, if any, in the contract and identification of the entity that controls the settlement alternatives including: a. The amount that would be paid, or the number of shares that would be issued and their fair value, determined under the conditions specified in the contract if the settlement were to occur at the reporting date b. How changes in the fair value of the issuer's equity shares would affect those settlement amounts (for example, \"the issuer is obligated to issue an additional x shares or pay an additional y dollars in cash for each $1 decrease in the fair value of one share\") c. The maximum amount that the issuer could be required to pay to redeem the instrument by physical settlement, if applicable d. The maximum number of shares that could be required to be issued, if applicable e. That a contract does not limit the amount that the issuer could be required to pay or the number of shares that the issuer could be required to issue, if applicable f. For a forward contract or an option indexed to the issuer's equity shares, the forward price or option strike price, the number of issuer's shares to which the contract is indexed, and the settlement date or dates of the contract, as applicable. g. The components of the liability that would otherwise be related to shareholders' interest and other comprehensive income (if any) subject to the redemption feature (for example, par value and other paid in amounts of mandatorily redeemable instruments are disclosed separately from the amount of retained earnings or accumulated deficit).", "label": "Shares Subject To Mandatory Redemption Disclosure [Table Text Block]", "terseLabel": "Schedule of common stock subject to possible redemption" } } }, "auth_ref": [] }, "dhacu_SponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SponsorMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for sponsor.", "label": "Sponsor [Member]", "terseLabel": "Sponsor" } } }, "auth_ref": [] }, "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "State", "terseLabel": "State" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r120", "r127", "r128", "r129", "r144", "r166", "r167", "r169", "r171", "r175", "r176", "r215", "r232", "r234", "r235", "r236", "r239", "r240", "r262", "r263", "r266", "r269", "r276", "r373", "r462", "r463", "r464", "r465", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r494", "r515", "r537", "r550", "r551", "r552", "r553", "r554", "r677", "r691", "r698" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r21", "r121", "r135", "r136", "r137", "r151", "r152", "r153", "r155", "r161", "r163", "r174", "r216", "r217", "r278", "r314", "r315", "r316", "r335", "r336", "r353", "r354", "r355", "r356", "r357", "r358", "r361", "r374", "r375", "r376", "r377", "r378", "r379", "r382", "r455", "r456", "r457", "r472", "r537" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r151", "r152", "r153", "r174", "r425", "r460", "r483", "r486", "r487", "r488", "r489", "r490", "r491", "r494", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r513", "r516", "r517", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r537", "r588" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r151", "r152", "r153", "r174", "r425", "r460", "r483", "r486", "r487", "r488", "r489", "r490", "r491", "r494", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r507", "r508", "r509", "r510", "r511", "r513", "r516", "r517", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r537", "r588" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r606", "r618", "r628", "r654" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Stock Issued", "terseLabel": "Common stock issued for legal settlement", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r29", "r30", "r31" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficitParenthetical" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of shares, net of offering cost (in shares)", "verboseLabel": "Number of shares issued", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r8", "r72", "r73", "r96", "r462", "r537", "r551" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsFounderSharesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of shares, net of offering cost", "verboseLabel": "Aggregate purchase price", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r8", "r72", "r73", "r96", "r472", "r537", "r551", "r594" ] }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRedeemedOrCalledDuringPeriodShares", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Stock Redeemed or Called During Period, Shares", "terseLabel": "Number of shares redeemed", "verboseLabel": "Aggregate shares redeemed", "documentation": "Number of stock bought back by the entity at the exercise price or redemption price." } } }, "auth_ref": [ "r8" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Stockholders' Deficit", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r73", "r76", "r77", "r90", "r496", "r512", "r538", "r539", "r583", "r595", "r693", "r722", "r765", "r780" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders' Deficit" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' DEFICIT" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS' DEFICIT", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r93", "r143", "r261", "r263", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r275", "r278", "r360", "r540", "r542", "r555" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "terseLabel": "SUBSEQUENT EVENTS", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r380", "r392" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r380", "r392" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r380", "r392" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r380", "r392" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r380", "r392" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r391", "r393" ] }, "dhacu_SubsequentPlacementsPercentageOfSecuritiesToBeOffered": { "xbrltype": "percentItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "SubsequentPlacementsPercentageOfSecuritiesToBeOffered", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of offered securities to the PIPE investors in subsequent placements.", "label": "Subsequent Placements, Percentage of Securities to be Offered", "terseLabel": "Percentage of offered securities in subsequent placements" } } }, "auth_ref": [] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "documentation": "Different names of stock transactions and the different attributes of each transaction." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosurePrivatePlacementDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiary, Sale of Stock [Line Items]", "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS", "verboseLabel": "PRIVATE PLACEMENT", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r647" ] }, "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfChangesInStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Accretion to Redemption Value, Adjustment", "negatedLabel": "Accretion of common stock subject to redemption value", "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders." } } }, "auth_ref": [] }, "dhacu_TemporaryEquityAccretionToRedemptionValueAggregate": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "TemporaryEquityAccretionToRedemptionValueAggregate", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "documentation": "The aggregate accretion to redemption value of stock classified as temporary equity.", "label": "Temporary Equity, Accretion to Redemption Value Aggregate", "terseLabel": "Accretion of carrying value to redemption value" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityByClassOfStockTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityByClassOfStockTable", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, by Class of Stock [Table]", "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable." } } }, "auth_ref": [ "r11", "r40" ] }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityCarryingAmountAttributableToParent", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Common stock subject to possible redemption", "verboseLabel": "Common stock, $0.0001 par value;, subject to possible redemption, of: 114,966 and 694,123 shares issued and outstanding at redemption value of $11.15 and $10.65 per share, as of December 31, 2023 and 2022, respectively", "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r232", "r234", "r235", "r236", "r239", "r240", "r317", "r445" ] }, "us-gaap_TemporaryEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityLineItems", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "label": "Temporary Equity [Line Items]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dhacu_TemporaryEquityOfferingCostsAllocatedToOrdinarySharesSubjectToPossibleRedemption": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "TemporaryEquityOfferingCostsAllocatedToOrdinarySharesSubjectToPossibleRedemption", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of offering costs allocated to Class A ordinary shares subject to possible redemption recognized as a reduction to carrying value of temporary equity.", "label": "Temporary Equity Offering Costs Allocated To Ordinary Shares Subject To Possible Redemption", "negatedLabel": "Common stock issuance costs" } } }, "auth_ref": [] }, "dhacu_TemporaryEquityPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "TemporaryEquityPolicyPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of accounting policy for temporary equity.", "label": "Temporary Equity, Policy [Policy Text Block]", "terseLabel": "Common Stock Subject to Possible Redemption" } } }, "auth_ref": [] }, "dhacu_TemporaryEquityPortionOfBalanceAttributableToProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "TemporaryEquityPortionOfBalanceAttributableToProceedsFromIssuanceInitialPublicOffering", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of temporary equity attributable to gross proceeds from initial public offering.", "label": "Temporary Equity Portion Of Balance Attributable To Proceeds from Issuance Initial Public Offering", "terseLabel": "Gross proceeds" } } }, "auth_ref": [] }, "dhacu_TemporaryEquityProceedsAllocatedToWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "TemporaryEquityProceedsAllocatedToWarrants", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of gross proceeds allocated from temporary equity to warrants.", "label": "Temporary Equity Proceeds Allocated To Warrants", "negatedLabel": "Proceeds allocated to public warrants" } } }, "auth_ref": [] }, "dhacu_TemporaryEquityRedemptionOnCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "TemporaryEquityRedemptionOnCommonStock", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCommonStockReflectedInCondensedConsolidatedBalanceSheetDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of temporary equity redemption on common stock.", "label": "Temporary Equity Redemption On Common Stock", "terseLabel": "Redemptions" } } }, "auth_ref": [] }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquityRedemptionPricePerShare", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temporary equity, redemption price, (per share)", "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r11", "r40" ] }, "us-gaap_TemporaryEquitySharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesIssued", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureStockholdersDeficitCommonSharesDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Issued", "terseLabel": "Common stock subject to possible redemption, issued (in shares)", "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r71" ] }, "us-gaap_TemporaryEquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TemporaryEquitySharesOutstanding", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedBalanceSheetParenthetical" ], "lang": { "en-us": { "role": { "label": "Temporary Equity, Shares Outstanding", "verboseLabel": "Common stock subject to possible redemption, shares outstanding", "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer." } } }, "auth_ref": [ "r71" ] }, "dhacu_TemporaryEquityStockRedeemedOrCalledDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "TemporaryEquityStockRedeemedOrCalledDuringPeriodValue", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "The impact of the value of stock, classified as temporary equity bought back by the entity at the exercise price or redemption price.", "label": "Temporary Equity, Stock Redeemed or Called During Period, Value", "terseLabel": "Value of shares redeemed" } } }, "auth_ref": [] }, "dhacu_TermByWhichPeriodToConsummateInitialBusinessCombinationExtended": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "TermByWhichPeriodToConsummateInitialBusinessCombinationExtended", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Term by which the period to consummate the initial business combination extended by the company.", "label": "Term By Which The Period To Consummate Initial Business Combination Extended", "terseLabel": "Term by which the period to consummate initial business combination extended" } } }, "auth_ref": [] }, "dhacu_ThresholdConsecutiveTradingDaysPriorToDateOfLetter": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ThresholdConsecutiveTradingDaysPriorToDateOfLetter", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Threshold consecutive trading days prior to the date of letter", "label": "Threshold Consecutive Trading Days Prior to Date of Letter", "terseLabel": "Threshold consecutive trading days prior to the date of letter" } } }, "auth_ref": [] }, "dhacu_ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetHeldInTrustAccount": { "xbrltype": "pureItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "ThresholdMinimumAggregateFairMarketValueAsPercentageOfAssetHeldInTrustAccount", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "The threshold percentage of fair market value of target business to net balance of the trust account.", "label": "Threshold Minimum Aggregate Fair Market Value As Percentage Of Asset Held In Trust Account", "terseLabel": "Threshold minimum aggregate fair market value as a percentage of the net assets held in the trust account" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r639" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r646" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r667" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r669" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dhacu_TransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "TransactionCosts", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of transaction costs incurred.", "label": "Transaction Costs", "totalLabel": "Transaction costs" } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsAdditionalInformationDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsUnobservableInputsForPipeForwardContractDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r257", "r274", "r359", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r451", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r718", "r719", "r720", "r721" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r670" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r671" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r669" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r669" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r672" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r670" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureFairValueMeasurementsTables", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r345" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r666" ] }, "dhacu_UnitsEachConsistingOfOneShareOfCommonStockAndOneRedeemableWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "UnitsEachConsistingOfOneShareOfCommonStockAndOneRedeemableWarrantMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Units, each consisting of one share of Common Stock and one redeemable warrant.", "label": "Units, Each Consisting Of One Share Of Common Stock And One Redeemable Warrant [Member]", "terseLabel": "Units, each consisting of one share of Common Stock and one Redeemable Warrant" } } }, "auth_ref": [] }, "dhacu_UnitsIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of new units issued during the period.", "label": "Units Issued During Period, Shares, New Issues", "terseLabel": "Sale of units, net of underwriting discounts (in shares)", "verboseLabel": "Number of units sold" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefits", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits", "documentation": "Amount of unrecognized tax benefits." } } }, "auth_ref": [ "r319", "r326" ] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized tax benefits accrued for interest and penalties", "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return." } } }, "auth_ref": [ "r325" ] }, "dhacu_UnsecuredPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "UnsecuredPromissoryNoteMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to unsecured promissory note.", "label": "Unsecured Promissory Note [Member]", "terseLabel": "Unsecured promissory note" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r36", "r37", "r38", "r113", "r114", "r116", "r117" ] }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "crdr": "credit", "calculation": { "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetailsImported": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "negatedLabel": "Change in valuation allowance", "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset." } } }, "auth_ref": [ "r329" ] }, "dhacu_VseeAndIdocMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "VseeAndIdocMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to VSee and iDoc.", "label": "VSee and iDoc [Member]", "terseLabel": "VSee and iDoc" } } }, "auth_ref": [] }, "dhacu_VseeCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "VseeCommonStockMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to vsee common stock.", "label": "Vsee Common Stock [Member]", "terseLabel": "VSee Common Stock" } } }, "auth_ref": [] }, "dhacu_VseeHealthIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "VseeHealthIncentivePlanMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the member information pertaining to Vsee Health Incentive Plan.", "label": "Vsee Health Incentive Plan [Member]", "terseLabel": "VSee Health Incentive Plan" } } }, "auth_ref": [] }, "dhacu_VseeMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "VseeMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Vsee.", "label": "Vsee", "terseLabel": "VSee" } } }, "auth_ref": [] }, "dhacu_VseeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "VseeNoteMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDefaultedBridgeNotesDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExchangeNoteExchangeFinancingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureSubsequentEventsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to VSee Note.", "label": "VSee Note [Member]", "terseLabel": "VSee Note" } } }, "auth_ref": [] }, "dhacu_WarrantExercisePeriodConditionOne": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantExercisePeriodConditionOne", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The period of time after completion of a business combination before a warrant may be exercised.", "label": "Warrant Exercise Period Condition One", "terseLabel": "Warrant exercise period condition one" } } }, "auth_ref": [] }, "dhacu_WarrantExercisePeriodConditionTwo": { "xbrltype": "durationItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantExercisePeriodConditionTwo", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The alternate period of time after completion of an initial public offering before a warrant may be exercised.", "label": "Warrant Exercise Period Condition Two", "terseLabel": "Warrant exercise period condition two" } } }, "auth_ref": [] }, "dhacu_WarrantExercisePriceAdjustmentMultiple": { "xbrltype": "pureItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantExercisePriceAdjustmentMultiple", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted exercise price.", "label": "Warrant Exercise Price Adjustment Multiple", "terseLabel": "Warrant exercise price adjustment multiple" } } }, "auth_ref": [] }, "dhacu_WarrantExerciseRestrictionThresholdPercentOfCommonStockOwned": { "xbrltype": "pureItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantExerciseRestrictionThresholdPercentOfCommonStockOwned", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the election that may be made where warrant holders would not be able to exercise their warrants to the extent that after such exercise, they would own over a certain percentage of common stock outstanding.", "label": "Warrant Exercise Restriction Threshold, Percent Of Common Stock Owned", "terseLabel": "Warrant exercise restriction threshold" } } }, "auth_ref": [] }, "dhacu_WarrantInstrumentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantInstrumentsPolicyTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of warrant instruments.", "label": "Warrant Instruments [Policy Text Block]", "terseLabel": "Warrant Instruments" } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureDescriptionOfOrganizationAndBusinessOperationsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Warrants", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r585", "r586", "r589", "r590", "r591", "r592" ] }, "dhacu_WarrantRedemptionConditionMinimumSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantRedemptionConditionMinimumSharePrice", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum trading price for the reporting entity's stock which must be achieved as a condition for redemption of the warrant.", "label": "Warrant Redemption Condition Minimum Share Price", "terseLabel": "Warrant redemption condition minimum share price" } } }, "auth_ref": [] }, "dhacu_WarrantRedemptionPriceAdjustmentMultiple": { "xbrltype": "pureItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantRedemptionPriceAdjustmentMultiple", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "In the event of dilution of the warrant, the multiple to be applied to the higher of the market price or the price of newly issued shares in order to obtain the adjusted redemption price.", "label": "Warrant Redemption Price Adjustment Multiple", "terseLabel": "Warrant redemption price adjustment multiple" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsNoteDisclosureAbstract", "lang": { "en-us": { "role": { "label": "WARRANTS" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding", "terseLabel": "Warrants outstanding", "verboseLabel": "Fair value of warrants", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsExtensionNoteExtensionFinancingAndBifurcatedDerivativeDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureInitialPublicOfferingDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsBridgeWarrantsDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Public warrants expiration term", "verboseLabel": "Warrants, exercise period", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r764" ] }, "dhacu_WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price.", "label": "Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50", "terseLabel": "Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50" } } }, "auth_ref": [] }, "dhacu_WarrantsIssuedAsFinancingCostInNote": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantsIssuedAsFinancingCostInNote", "crdr": "debit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The amount of warrants issued as financing cost in note.", "label": "Warrants issued as financing cost in Note", "verboseLabel": "Warrants issued as financing cost in Extension Note" } } }, "auth_ref": [] }, "dhacu_WarrantsNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantsNoteDisclosureTextBlock", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrants" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of warrants.", "label": "Warrants Note Disclosure [Text Block]", "terseLabel": "WARRANTS" } } }, "auth_ref": [] }, "dhacu_WarrantsOfferingCost": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantsOfferingCost", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsBridgeSecuritiesPurchaseAgreementDetails", "http://digitalhealthacquisitioncorp.com/role/DisclosureCommitmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of warrants offering cost.", "label": "Warrants Offering Cost", "terseLabel": "Net of offering cost" } } }, "auth_ref": [] }, "dhacu_WarrantsTradingDaysOnWhichFairMarketValueOfSharesIsReported": { "xbrltype": "integerItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WarrantsTradingDaysOnWhichFairMarketValueOfSharesIsReported", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureWarrantsDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of trading days on which fair market value of warrants is reported.", "label": "Warrants, Trading Days On Which Fair Market Value Of Shares Is Reported", "terseLabel": "Number of trading days to calculate fair market value of warrants" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCalculationOfBasicAndDilutedNetLossPerCommonStockDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted weighted average common shares outstanding (in shares)", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r165", "r171" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCalculationOfBasicAndDilutedNetLossPerCommonStockDetails" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Denominator:" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCalculationOfBasicAndDilutedNetLossPerCommonStockDetails", "http://digitalhealthacquisitioncorp.com/role/StatementConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic weighted average common shares outstanding (in shares)", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r164", "r171" ] }, "dhacu_WhackyMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WhackyMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Whacky.", "label": "Whacky [Member]", "terseLabel": "Whacky" } } }, "auth_ref": [] }, "dhacu_WorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WorkingCapital", "crdr": "credit", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount represents the information about the working capital.", "label": "Working Capital", "terseLabel": "Working capital" } } }, "auth_ref": [] }, "dhacu_WorkingCapitalLoansWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://digitalhealthacquisitioncorp.com/20231231", "localname": "WorkingCapitalLoansWarrantMember", "presentation": [ "http://digitalhealthacquisitioncorp.com/role/DisclosureRelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for working capital loans warrant.", "label": "Working Capital Loans Warrants [Member]", "terseLabel": "Working capital loans" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(27)", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-5" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.E.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r561": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r562": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r563": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r564": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r565": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r566": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r567": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r568": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r569": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r570": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r571": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r572": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r573": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r574": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r575": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r578": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r579": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r580": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r581": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r582": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r583": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r584": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r585": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r587": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r592": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r593": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r594": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r595": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r596": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r597": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r600": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r601": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r602": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r603": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r604": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r605": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r606": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r607": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r608": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r609": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r610": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r611": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r612": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r613": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r614": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r615": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r616": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r617": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r618": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r619": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r620": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r621": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r622": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r623": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r624": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r625": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r626": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r627": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r628": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r629": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r630": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r631": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r632": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r633": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r634": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r636": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r637": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r638": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r639": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r640": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r641": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r642": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r643": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r644": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r645": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r646": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r647": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r648": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r649": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r650": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r651": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r652": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r653": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r654": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r655": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r656": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r657": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r658": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r659": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r660": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r661": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r662": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r663": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r664": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r665": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r666": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r667": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r668": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r669": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r670": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r671": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r672": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r673": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r674": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r675": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r676": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r677": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r761": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r762": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r763": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r764": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r765": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r766": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r767": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r768": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r769": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r770": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r771": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r772": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r773": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r774": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r775": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r776": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r777": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r778": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r779": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r780": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r781": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } }